| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | CASP8AP2 NCOA3 DCAF6 ATN1 PHF24 ZMYND8 MAML1 BCOR TRIM24 HIRA MLIP BRDT CCDC62 ATF7IP2 TMF1 NCOA1 NCOA7 NIPBL TP53BP1 | 1.07e-07 | 562 | 158 | 19 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CASP8AP2 NCOA3 VPS11 DCAF6 ATN1 ANK2 MAP1A TCOF1 PHF24 ZMYND8 MAML1 IRAK2 BCOR TRIM24 HIRA BICD1 MLIP STX18 BRDT CCDC62 ATF7IP2 SLMAP TMF1 NCOA1 NCOA7 NIPBL NUP153 TP53BP1 | 1.14e-07 | 1160 | 158 | 28 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | CASP8AP2 NCOA3 VPS11 DCAF6 ATN1 ANK2 MAP1A TCOF1 PHF24 ZMYND8 MAML1 IRAK2 BCOR TRIM24 HIRA BICD1 MLIP STX18 BRDT CCDC62 ATF7IP2 SLMAP TMF1 NCOA1 NCOA7 PLCB3 NKAP NIPBL NUP153 TP53BP1 | 2.49e-07 | 1356 | 158 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 TSHZ3 ZNF609 RNF168 ASH1L SRF EYA3 SSRP1 TRIM24 HIRA WAC NFIX NCOA1 ANKRD17 MACROH2A2 CHD6 NKAP NIPBL TOP2A NUP153 | 1.63e-06 | 739 | 158 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 8.65e-06 | 61 | 158 | 6 | GO:0030374 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.35e-05 | 39 | 158 | 5 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 2.75e-05 | 45 | 158 | 5 | GO:0043175 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.54e-04 | 303 | 158 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.64e-04 | 65 | 158 | 5 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.76e-04 | 66 | 158 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.76e-04 | 66 | 158 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.88e-04 | 229 | 158 | 8 | GO:0003714 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.02e-04 | 20 | 158 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 6.13e-04 | 5 | 158 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 8.71e-04 | 24 | 158 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 9.84e-04 | 25 | 158 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.24e-03 | 27 | 158 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | histone binding | 1.26e-03 | 265 | 158 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.69e-03 | 30 | 158 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.86e-03 | 31 | 158 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MYC NCOA3 ZMYND8 SRF BCOR TRIM24 HIRA CCDC62 TMF1 NCOA1 NCOA7 TP53BP1 | 2.34e-03 | 582 | 158 | 12 | GO:0140297 |
| GeneOntologyBiologicalProcess | chromatin organization | MYC NCOA3 RNF168 ZMYND8 ASH1L TEX15 EYA3 SSRP1 BCOR HIRA WAC SETD2 BRDT TET1 ATF7IP2 MKI67 ERCC6L2 NCOA1 MACROH2A2 CHD6 NIPBL TP53BP1 | 9.95e-07 | 896 | 155 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYC NCOA3 RNF168 ASH1L TEX15 EYA3 SSRP1 BCOR HIRA WAC SETD2 BRDT TET1 ATF7IP2 ERCC6L2 NCOA1 MACROH2A2 CHD6 NIPBL | 3.13e-06 | 741 | 155 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MYC NCOA3 RNF168 ZMYND8 ASH1L TEX15 EYA3 SSRP1 BCOR HIRA WAC SETD2 BRDT TET1 ATF7IP2 MKI67 ERCC6L2 NCOA1 MACROH2A2 CHD6 NIPBL TP53BP1 | 5.81e-06 | 999 | 155 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.35e-05 | 20 | 155 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.42e-05 | 145 | 155 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RANBP2 VPS11 ANK2 RGPD8 MAP1A ZMYND8 PCARE NUP214 DNAAF11 TEX15 STIL ADAR BICD1 FSIP2 SETD2 RGPD3 MACROH2A2 POM121B NIPBL NUP153 TP53BP1 RGPD5 | 2.29e-05 | 1091 | 155 | 22 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.38e-05 | 9 | 155 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | DNA damage response | MYC ERCC5 RNF168 RBBP6 ZMYND8 TEX15 EYA3 SSRP1 CINP WAC FANCD2 RAD51AP1 SETD2 ERCC6L2 MARF1 ZBTB40 CLSPN NIPBL TOP2A TP53BP1 | 3.49e-05 | 959 | 155 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | double-strand break repair | ERCC5 RNF168 ZMYND8 TEX15 EYA3 FANCD2 RAD51AP1 SETD2 MARF1 NIPBL TP53BP1 | 3.52e-05 | 324 | 155 | 11 | GO:0006302 |
| GeneOntologyBiologicalProcess | RNA localization | 3.99e-05 | 217 | 155 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.81e-05 | 10 | 155 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | RNA transport | 5.46e-05 | 175 | 155 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 5.46e-05 | 175 | 155 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 6.15e-05 | 178 | 155 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 8.06e-05 | 185 | 155 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 8.13e-05 | 238 | 155 | 9 | GO:0050954 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.13e-04 | 13 | 155 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | DNA repair | ERCC5 RNF168 ZMYND8 TEX15 EYA3 SSRP1 CINP FANCD2 RAD51AP1 SETD2 ERCC6L2 MARF1 CLSPN NIPBL TP53BP1 | 1.14e-04 | 648 | 155 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.16e-04 | 195 | 155 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | intracellular transport | RANBP2 VPS11 REPS1 RGPD8 MAP1A MAP1B MAP6 AHCTF1 NUP214 ADAR CLIP1 BICD1 SETD2 UBE2O IGF2R MIA2 STX18 CLMN RGPD3 EXOC6B LRBA POM121B ARHGAP21 NUP153 RGPD5 | 1.32e-04 | 1496 | 155 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.43e-04 | 14 | 155 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.43e-04 | 201 | 155 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | response to ionizing radiation | 1.48e-04 | 151 | 155 | 7 | GO:0010212 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | MYC ERCC5 RNF168 RBBP6 ZMYND8 TEX15 EYA3 SSRP1 CINP FANCD2 RAD51AP1 SETD2 NFIX ERCC6L2 MARF1 ANKRD17 CLSPN NIPBL TOP2A TP53BP1 | 1.79e-04 | 1081 | 155 | 20 | GO:0006259 |
| GeneOntologyBiologicalProcess | interstrand cross-link repair | 2.75e-04 | 42 | 155 | 4 | GO:0036297 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MYC NCOA3 DCAF6 ZNF609 HIVEP2 ZMYND8 ASH1L MAML1 SRF ZNF407 HOXA1 MLIP ZSCAN21 NFIX CCDC62 TET1 TMF1 NCOA1 NCOA7 CHD6 NIPBL TOP2A TP53BP1 | 2.91e-04 | 1390 | 155 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | nuclear pore organization | 3.13e-04 | 18 | 155 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP1A MAP1B MAP6 SPEF2 DNAAF11 STIL CLIP1 CEP43 CDC14A BICD1 FSIP2 SETD2 TTLL4 RP1 NLRP5 | 3.55e-04 | 720 | 155 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 3.77e-04 | 176 | 155 | 7 | GO:0070507 | |
| GeneOntologyBiologicalProcess | response to radiation | MYC ERCC5 RNF168 PCARE EYA3 HOXA1 FANCD2 RAD51AP1 N4BP1 RP1 NIPBL TP53BP1 | 4.31e-04 | 503 | 155 | 12 | GO:0009314 |
| GeneOntologyBiologicalProcess | DNA recombination | ERCC5 RNF168 ZMYND8 TEX15 FANCD2 RAD51AP1 SETD2 NIPBL TOP2A TP53BP1 | 4.81e-04 | 368 | 155 | 10 | GO:0006310 |
| GeneOntologyBiologicalProcess | cell cycle process | MYC AHCTF1 TEX15 STIL ANKLE2 CDC14A WAC FANCD2 RAD51AP1 SETD2 BRDT ZSCAN21 NFIX MKI67 MARF1 EXOC6B ANKRD17 CLSPN NIPBL TOP2A TP53BP1 KCNH5 NLRP5 | 4.83e-04 | 1441 | 155 | 23 | GO:0022402 |
| GeneOntologyBiologicalProcess | nuclear division | TEX15 ANKLE2 CDC14A FANCD2 RAD51AP1 BRDT ZSCAN21 NFIX MKI67 MARF1 NIPBL TOP2A | 5.04e-04 | 512 | 155 | 12 | GO:0000280 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 5.59e-04 | 188 | 155 | 7 | GO:0000724 | |
| GeneOntologyBiologicalProcess | nuclear transport | RANBP2 RGPD8 AHCTF1 NUP214 ADAR SETD2 RGPD3 POM121B NUP153 RGPD5 | 5.92e-04 | 378 | 155 | 10 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RANBP2 RGPD8 AHCTF1 NUP214 ADAR SETD2 RGPD3 POM121B NUP153 RGPD5 | 5.92e-04 | 378 | 155 | 10 | GO:0006913 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 6.04e-04 | 249 | 155 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome | 6.70e-04 | 140 | 155 | 6 | GO:0034502 | |
| GeneOntologyBiologicalProcess | recombinational repair | 6.73e-04 | 194 | 155 | 7 | GO:0000725 | |
| GeneOntologyCellularComponent | nuclear pore | 9.02e-07 | 101 | 156 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.82e-06 | 14 | 156 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 8.42e-06 | 18 | 156 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.32e-05 | 20 | 156 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear envelope | RANBP2 RGPD8 AHCTF1 PARP8 NUP214 CLIP1 CLCC1 IGF2R MLIP CLMN RGPD3 ANKRD17 POM121B NUP153 RGPD5 | 2.04e-05 | 560 | 156 | 15 | GO:0005635 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.22e-05 | 8 | 156 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.71e-05 | 10 | 156 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.91e-04 | 21 | 156 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MYC NCOA3 RANBP2 ERCC5 RGPD8 POLR3H AHCTF1 NUP214 SSRP1 BCOR ADAR WAC PRPF4 CLMN RGPD3 TET1 NCOA1 AFF1 POM121B NIPBL NUP153 RGPD5 | 5.85e-04 | 1377 | 156 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | DNA repair complex | 6.47e-04 | 23 | 156 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | non-motile cilium | 6.87e-04 | 196 | 156 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.03e-03 | 153 | 156 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | nuclear body | MYC CASP8AP2 RBBP6 AHCTF1 MAML1 ADAR CDC14A HIRA WAC FANCD2 UBE2O MLIP PRPF4 MKI67 N4BP1 TP53BP1 | 1.20e-03 | 903 | 156 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear membrane | 1.27e-03 | 349 | 156 | 9 | GO:0031965 | |
| HumanPheno | Prominent fingertip pads | 1.22e-05 | 46 | 59 | 6 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 1.57e-05 | 48 | 59 | 6 | HP:0011298 | |
| MousePheno | failure of blastocyst formation | 8.04e-06 | 31 | 127 | 5 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 2.57e-05 | 39 | 127 | 5 | MP:0012128 | |
| Domain | Ran_BP1 | 2.04e-06 | 12 | 153 | 4 | PF00638 | |
| Domain | RANBD1 | 2.04e-06 | 12 | 153 | 4 | PS50196 | |
| Domain | RanBD | 2.92e-06 | 13 | 153 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 2.92e-06 | 13 | 153 | 4 | IPR000156 | |
| Domain | Grip | 8.48e-05 | 11 | 153 | 3 | SM00755 | |
| Domain | GRIP | 8.48e-05 | 11 | 153 | 3 | PF01465 | |
| Domain | GRIP_dom | 1.12e-04 | 12 | 153 | 3 | IPR000237 | |
| Domain | GRIP | 1.12e-04 | 12 | 153 | 3 | PS50913 | |
| Domain | DUF1518 | 1.99e-04 | 3 | 153 | 2 | PF07469 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 1.99e-04 | 3 | 153 | 2 | IPR014920 | |
| Domain | SRC-1 | 1.99e-04 | 3 | 153 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 1.99e-04 | 3 | 153 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 1.99e-04 | 3 | 153 | 2 | IPR017426 | |
| Domain | - | 1.99e-04 | 3 | 153 | 2 | 4.10.630.10 | |
| Domain | DUF1518 | 1.99e-04 | 3 | 153 | 2 | IPR010011 | |
| Domain | MAP1 | 1.99e-04 | 3 | 153 | 2 | IPR026074 | |
| Domain | DUF1518 | 1.99e-04 | 3 | 153 | 2 | SM01151 | |
| Domain | SRC-1 | 1.99e-04 | 3 | 153 | 2 | PF08832 | |
| Domain | Nuc_rec_co-act | 1.99e-04 | 3 | 153 | 2 | PF08815 | |
| Domain | Bromodomain | 2.57e-04 | 38 | 153 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.46e-04 | 41 | 153 | 4 | PS50014 | |
| Domain | Bromodomain | 3.80e-04 | 42 | 153 | 4 | IPR001487 | |
| Domain | BROMO | 3.80e-04 | 42 | 153 | 4 | SM00297 | |
| Domain | - | 3.80e-04 | 42 | 153 | 4 | 1.20.920.10 | |
| Domain | AWS | 6.56e-04 | 5 | 153 | 2 | SM00570 | |
| Domain | AWS | 6.56e-04 | 5 | 153 | 2 | PS51215 | |
| Domain | AWS_dom | 6.56e-04 | 5 | 153 | 2 | IPR006560 | |
| Domain | PH_dom-like | RANBP2 RGPD8 SSRP1 ARHGEF17 TBC1D1 RGPD3 PLCB3 LRBA TNS1 ARHGAP21 RGPD5 | 7.86e-04 | 426 | 153 | 11 | IPR011993 |
| Domain | Nuc_rcpt_coact | 9.79e-04 | 6 | 153 | 2 | IPR009110 | |
| Domain | PAS | 1.09e-03 | 25 | 153 | 3 | PF00989 | |
| Domain | PAS_fold | 1.09e-03 | 25 | 153 | 3 | IPR013767 | |
| Domain | RNA_pol_II-bd | 1.36e-03 | 7 | 153 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.36e-03 | 7 | 153 | 2 | PF04818 | |
| Domain | Rab_bind | 1.36e-03 | 7 | 153 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.36e-03 | 7 | 153 | 2 | IPR032023 | |
| Domain | RPR | 1.81e-03 | 8 | 153 | 2 | SM00582 | |
| Domain | CID_dom | 1.81e-03 | 8 | 153 | 2 | IPR006569 | |
| Domain | TMC | 1.81e-03 | 8 | 153 | 2 | PF07810 | |
| Domain | CID | 1.81e-03 | 8 | 153 | 2 | PS51391 | |
| Domain | TMC | 1.81e-03 | 8 | 153 | 2 | IPR012496 | |
| Domain | Zinc_finger_PHD-type_CS | 1.99e-03 | 65 | 153 | 4 | IPR019786 | |
| Domain | PAS | 2.25e-03 | 32 | 153 | 3 | SM00091 | |
| Domain | PAS | 2.68e-03 | 34 | 153 | 3 | PS50112 | |
| Domain | PAS | 2.68e-03 | 34 | 153 | 3 | IPR000014 | |
| Domain | - | 2.87e-03 | 10 | 153 | 2 | 1.10.220.60 | |
| Domain | BROMODOMAIN_1 | 3.42e-03 | 37 | 153 | 3 | PS00633 | |
| Domain | - | 4.17e-03 | 12 | 153 | 2 | 3.40.50.1010 | |
| Domain | - | 4.40e-03 | 248 | 153 | 7 | 1.25.40.20 | |
| Domain | ANK | 4.69e-03 | 251 | 153 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 4.90e-03 | 253 | 153 | 7 | PS50088 | |
| Domain | - | RANBP2 RGPD8 SSRP1 ARHGEF17 TBC1D1 RGPD3 PLCB3 TNS1 ARHGAP21 | 5.00e-03 | 391 | 153 | 9 | 2.30.29.30 |
| Domain | Ankyrin_rpt-contain_dom | 5.00e-03 | 254 | 153 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.00e-03 | 254 | 153 | 7 | PS50297 | |
| Domain | PIN_domain-like | 5.69e-03 | 14 | 153 | 2 | IPR029060 | |
| Domain | Ankyrin_rpt | 5.91e-03 | 262 | 153 | 7 | IPR002110 | |
| Domain | Znf_PHD | 6.67e-03 | 91 | 153 | 4 | IPR001965 | |
| Domain | WW | 6.71e-03 | 47 | 153 | 3 | PF00397 | |
| Domain | WW | 7.12e-03 | 48 | 153 | 3 | SM00456 | |
| Domain | Post-SET_dom | 7.42e-03 | 16 | 153 | 2 | IPR003616 | |
| Domain | PostSET | 7.42e-03 | 16 | 153 | 2 | SM00508 | |
| Domain | POST_SET | 7.42e-03 | 16 | 153 | 2 | PS50868 | |
| Domain | ZF_PHD_2 | 7.75e-03 | 95 | 153 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 8.03e-03 | 96 | 153 | 4 | PS01359 | |
| Pathway | REACTOME_SUMOYLATION | CASP8AP2 RANBP2 RNF168 RGPD8 NUP214 RGPD3 NCOA1 POM121B TOP2A NUP153 TP53BP1 | 4.52e-08 | 169 | 104 | 11 | MM14919 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.46e-08 | 49 | 104 | 7 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 8.60e-08 | 51 | 104 | 7 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.37e-07 | 40 | 104 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.08e-07 | 41 | 104 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.90e-07 | 42 | 104 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.81e-07 | 43 | 104 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.17e-06 | 47 | 104 | 6 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.70e-06 | 50 | 104 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.76e-06 | 84 | 104 | 7 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.02e-06 | 55 | 104 | 6 | MM14917 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.86e-06 | 5 | 104 | 3 | M48983 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.14e-06 | 58 | 104 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.14e-06 | 58 | 104 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.09e-06 | 65 | 104 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.59e-05 | 73 | 104 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.10e-05 | 82 | 104 | 6 | MM15394 | |
| Pathway | REACTOME_CELL_CYCLE | RANBP2 RNF168 RGPD8 AHCTF1 NUP214 ANKLE2 CLIP1 CEP43 CDC14A RGPD3 CLSPN POM121B NIPBL NUP153 TP53BP1 | 3.45e-05 | 603 | 104 | 15 | MM14635 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.07e-05 | 86 | 104 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.95e-05 | 92 | 104 | 6 | MM14951 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 6.17e-05 | 11 | 104 | 3 | M22033 | |
| Pathway | REACTOME_SUMOYLATION | 7.74e-05 | 189 | 104 | 8 | M27214 | |
| Pathway | REACTOME_M_PHASE | RANBP2 RGPD8 AHCTF1 NUP214 ANKLE2 CLIP1 CEP43 RGPD3 POM121B NIPBL NUP153 | 1.31e-04 | 387 | 104 | 11 | MM15364 |
| Pathway | REACTOME_CELL_CYCLE | MYC RANBP2 RNF168 AHCTF1 NUP214 TEX15 ANKLE2 CLIP1 CEP43 CDC14A CLSPN NIPBL TOP2A NUP153 TP53BP1 | 1.67e-04 | 694 | 104 | 15 | M543 |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.95e-04 | 114 | 104 | 6 | MM15361 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.94e-04 | 18 | 104 | 3 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.60e-04 | 46 | 104 | 4 | M27397 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.12e-04 | 141 | 104 | 6 | MM15266 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 8.58e-04 | 100 | 104 | 5 | MM14561 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 8.82e-04 | 271 | 104 | 8 | MM15388 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.02e-03 | 277 | 104 | 8 | MM15414 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 1.26e-03 | 109 | 104 | 5 | M39542 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 1.26e-03 | 64 | 104 | 4 | M200 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.47e-03 | 8 | 104 | 2 | M42528 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 REPS1 ANK2 MAP1A MAP1B TCOF1 RBBP6 AHCTF1 ZMYND8 AAK1 TNRC6B ZNF318 NUP214 BCOR GPRIN1 ADAR SCAF4 WAC CSDE1 SETD2 UBE2O FAM193A SYNJ1 CLMN MKI67 ANKRD17 NCOA7 RPRD2 LRBA NIPBL ARHGAP21 TOP2A NUP153 TP53BP1 AHNAK2 FTSJ3 | 8.05e-23 | 934 | 162 | 36 | 33916271 |
| Pubmed | CASP8AP2 NCOA3 RANBP2 TSHZ3 ZNF609 RGPD8 ZMYND8 TNRC6B ZNF318 NUP214 BCOR TRIM24 FAM193A ZNF608 SYNJ1 RGPD3 TET1 ATF7IP2 TMF1 ANKRD17 CHD6 LRBA ARHGAP21 | 4.03e-18 | 418 | 162 | 23 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 RANBP2 ERCC5 ATN1 TCOF1 RBBP6 ZMYND8 FNBP4 AAK1 ZNF318 NUP214 SSRP1 BCOR GPRIN1 CLIP1 SCAF4 FANCD2 SETD2 MKI67 ZBTB40 ANKRD17 AFF1 PLCB3 NKAP PRG4 NIPBL TOP2A NUP153 TP53BP1 | 4.08e-18 | 774 | 162 | 29 | 15302935 |
| Pubmed | REPS1 MAP1B TCOF1 RBBP6 AHCTF1 FNBP4 TNRC6B ZNF318 SSRP1 BCOR GPRIN1 ADAR SCAF4 CSDE1 SETD2 UBE2O SYNJ1 TET1 RPRD2 PEAK1 LRBA TOP2A TP53BP1 RGPD5 | 1.32e-16 | 549 | 162 | 24 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 ZNF609 MAP1B RBBP6 AHCTF1 ZMYND8 FNBP4 ZNF318 NUP214 SSRP1 BCOR TRIM24 ADAR SCAF4 WAC RAD51AP1 SETD2 ZSCAN21 PRPF4 MKI67 MARF1 RPRD2 NIPBL TOP2A NUP153 TP53BP1 FTSJ3 | 5.91e-14 | 954 | 162 | 27 | 36373674 |
| Pubmed | MYC NCOA3 TSHZ3 ZNF609 ATN1 RBBP6 ZMYND8 MAML1 TNRC6B ZNF318 NUP214 EYA3 BCOR TRIM24 SCAF4 HIRA UBE2O ZNF608 ZSCAN21 NFIX MKI67 MARF1 ZBTB40 NCOA1 ANKRD17 RPRD2 N4BP1 CHD6 NIPBL TP53BP1 FILIP1L FTSJ3 | 1.29e-13 | 1429 | 162 | 32 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYC CASP8AP2 RANBP2 ZNF609 RNF168 TCOF1 RBBP6 AHCTF1 ZMYND8 FNBP4 ZNF318 NUP214 SSRP1 BCOR ADAR SCAF4 HIRA WAC SETD2 ZSCAN21 PRPF4 NFIX RGPD3 MKI67 RPRD2 CHD6 NIPBL TOP2A NUP153 FTSJ3 | 3.48e-13 | 1294 | 162 | 30 | 30804502 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | RANBP2 ZMYND8 ASH1L MUC19 TNRC6B ZNF318 NUP214 BCOR FSIP2 NKAP NUP153 AHNAK2 | 6.36e-13 | 123 | 162 | 12 | 26912792 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 RANBP2 TSHZ3 ZNF609 HIVEP2 ATN1 MAML1 NUP214 BCOR TRIM24 HIRA ZNF608 TET1 MKI67 NCOA1 NIPBL TOP2A | 9.07e-13 | 351 | 162 | 17 | 38297188 |
| Pubmed | RANBP2 AHCTF1 TNRC6B ZNF318 ANKLE2 UBE2O FAM193A MKI67 TMEM131 N4BP1 PEAK1 LRBA ARHGAP21 NUP153 AHNAK2 | 2.05e-12 | 263 | 162 | 15 | 34702444 | |
| Pubmed | MYC DCAF6 ZNF609 ATN1 MAP1A TCOF1 RBBP6 AHCTF1 ZMYND8 ASH1L TNRC6B ZNF318 SSRP1 BCOR TRIM24 FANCD2 RAD51AP1 SETD2 ZNF608 BRDT PRPF4 ANKRD17 MACROH2A2 NKAP CLSPN TOP2A FTSJ3 | 2.31e-12 | 1116 | 162 | 27 | 31753913 | |
| Pubmed | NCOA3 ZNF609 ATN1 ZMYND8 MAML1 BCOR TRIM24 HIRA WAC ZNF608 ZSCAN21 NFIX NCOA1 RPRD2 NIPBL | 2.69e-12 | 268 | 162 | 15 | 33640491 | |
| Pubmed | NCOA3 RANBP2 TCOF1 RBBP6 AHCTF1 AAK1 ANKLE2 ADAR CLIP1 WAC MKI67 TMF1 RPRD2 TMEM131 NIPBL TOP2A NUP153 TP53BP1 FTSJ3 | 3.09e-12 | 503 | 162 | 19 | 16964243 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANBP2 ZNF609 REPS1 MAP1A MAP1B AAK1 TNRC6B ZNF318 EYA3 BCOR TRIM24 HIRA CSDE1 ZNF608 PRPF4 RGPD3 TOP2A AHNAK2 | 3.70e-12 | 444 | 162 | 18 | 34795231 |
| Pubmed | 4.50e-11 | 15 | 162 | 6 | 14697343 | ||
| Pubmed | NCOA3 RANBP2 ANK2 RGPD8 TCOF1 MAP6 AAK1 TNRC6B ZNF318 BCOR CLIP1 HIRA UBE2O IGF2R KCNB1 SYNJ1 RGPD3 ANKRD17 TNS1 NIPBL ARHGAP21 NUP153 TP53BP1 | 1.49e-10 | 963 | 162 | 23 | 28671696 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MYC TSHZ3 ZNF609 ATN1 LRRN1 MAP1A TCOF1 RBBP6 ZMYND8 NUP214 FAM193A MIA2 ATF7IP2 AFF1 CLSPN NUP153 | 2.18e-10 | 430 | 162 | 16 | 35044719 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 4.67e-10 | 38 | 162 | 7 | 12791264 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RANBP2 ANK2 TCOF1 AHCTF1 ZNF318 SSRP1 ADAR MKI67 RPRD2 TOP2A NUP153 TP53BP1 FTSJ3 | 5.41e-10 | 271 | 162 | 13 | 32433965 |
| Pubmed | RANBP2 REPS1 ANK2 MAP1B TCOF1 AHCTF1 AAK1 TNRC6B NUP214 GPRIN1 ANKLE2 CLCC1 CSDE1 IGF2R ANKRD17 PEAK1 LRBA ARHGAP21 NUP153 | 1.01e-09 | 708 | 162 | 19 | 39231216 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MAP1A RBBP6 TNRC6B ZNF318 STIL BCOR TRIM24 ANKLE2 FAM193A MKI67 RPRD2 | 1.20e-09 | 184 | 162 | 11 | 32908313 |
| Pubmed | ERCC5 MAP6 AHCTF1 ASH1L ZNF318 BCOR ANKLE2 IGF2R SYNJ1 ZSCAN21 CLMN TTLL4 TET1 ZBTB40 ANKRD17 AFF1 TMEM131 PEAK1 SUCO TNS1 ARHGAP21 NUP153 TP53BP1 | 1.45e-09 | 1084 | 162 | 23 | 11544199 | |
| Pubmed | RANBP2 IP6K1 NUP214 GPRIN1 ANKLE2 CLCC1 CSDE1 IGF2R CLMN MKI67 NUP153 | 1.78e-09 | 191 | 162 | 11 | 31177093 | |
| Pubmed | NCOA3 RANBP2 ZNF609 ZMYND8 MAML1 ZNF318 EYA3 SSRP1 BCOR TRIM24 ADAR SCAF4 WAC CSDE1 ZSCAN21 PRPF4 MKI67 ZBTB40 NCOA1 NIPBL TOP2A NUP153 TP53BP1 | 2.02e-09 | 1103 | 162 | 23 | 34189442 | |
| Pubmed | RANBP2 RNF168 MAP1B RBBP6 NUP214 SETD2 PRPF4 MKI67 TOP2A NUP153 TP53BP1 FTSJ3 | 2.53e-09 | 250 | 162 | 12 | 33536335 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 TCOF1 FNBP4 ZNF318 NUP214 SSRP1 ADAR SETD2 MKI67 ANKRD17 RPRD2 TOP2A NUP153 TP53BP1 FTSJ3 | 2.69e-09 | 440 | 162 | 15 | 34244565 |
| Pubmed | CYLC1 RPGRIP1 RANBP2 KRT12 ERCC5 ANK2 RGPD8 MAP1B SPEF2 PARP8 ASH1L ANKRD30B ZNF318 SSRP1 ANKLE2 RAD51AP1 MLIP MIA2 ZNF608 RGPD3 MARF1 CHD6 NIPBL ARHGAP21 TOP2A RGPD5 | 3.37e-09 | 1442 | 162 | 26 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TSHZ3 RNF168 AHCTF1 EYA3 SSRP1 BCOR TRIM24 HIRA FSIP2 RAD51AP1 UBE2O ZSCAN21 MKI67 ZBTB40 CHD6 NIPBL TOP2A | 4.40e-09 | 608 | 162 | 17 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DCAF6 ZNF609 HIVEP2 LRRN1 MAP1B ASH1L FNBP4 AAK1 SRF TNRC6B CEP43 CLCC1 BICD1 CSDE1 HIVEP3 ZNF608 CLMN TBC1D1 NFIX EXOC6B ANKRD17 AFF1 RPRD2 MACROH2A2 CHD6 LRBA | 6.50e-09 | 1489 | 162 | 26 | 28611215 |
| Pubmed | MYC MAML1 MUC19 ZNF318 SSRP1 BCOR TRIM24 SCAF4 PRPF4 RPRD2 N4BP1 CLSPN FTSJ3 | 8.03e-09 | 339 | 162 | 13 | 30415952 | |
| Pubmed | ZNF609 RGPD8 MAML1 TNRC6B NUP214 CLCC1 SETD2 UBE2O IGF2R FAM193A CLMN TTLL4 TMF1 RPRD2 TMEM131 N4BP1 CHD6 CLSPN | 1.12e-08 | 733 | 162 | 18 | 34672954 | |
| Pubmed | 3.04e-08 | 103 | 162 | 8 | 32744500 | ||
| Pubmed | ZNF609 REPS1 MAP1A ZMYND8 TNRC6B EYA3 ADAR CLIP1 CEP43 SCAF4 IGF2R RPRD2 ARHGAP21 TP53BP1 | 5.27e-08 | 472 | 162 | 14 | 38943005 | |
| Pubmed | AHCTF1 SCYL3 TNRC6B NUP214 EYA3 SSRP1 GPRIN1 ANKLE2 CEP43 CLCC1 WAC CSDE1 RAD51AP1 IGF2R SYNJ1 TMF1 TMEM131 N4BP1 PEAK1 LRBA | 5.52e-08 | 1007 | 162 | 20 | 34597346 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.61e-08 | 9 | 162 | 4 | 18394993 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBBP6 AHCTF1 ZMYND8 ZNF318 SSRP1 ADAR WAC MKI67 RPRD2 TOP2A NUP153 | 1.03e-07 | 283 | 162 | 11 | 30585729 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 AAK1 MAML1 TNRC6B STIL ANKLE2 CLIP1 CLCC1 BICD1 CSDE1 IGF2R SYNJ1 TBC1D1 TMEM131 NKAP ARHGAP21 TOP2A FTSJ3 | 1.10e-07 | 853 | 162 | 18 | 28718761 |
| Pubmed | TCOF1 RBBP6 AHCTF1 FNBP4 ZNF318 SCAF4 WAC UBE2O SYNJ1 PRPF4 MKI67 RPRD2 NUP153 TP53BP1 | 1.23e-07 | 506 | 162 | 14 | 30890647 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP2 MAP1B PARP8 AAK1 STIL SSRP1 ARHGEF17 CDC14A FSIP2 SYNJ1 CLMN TBC1D1 TET1 ANKRD17 NCOA7 PEAK1 ARHGAP21 AHNAK2 | 1.26e-07 | 861 | 162 | 18 | 36931259 |
| Pubmed | 1.46e-07 | 11 | 162 | 4 | 17069463 | ||
| Pubmed | DCAF6 HIVEP2 REPS1 ANK2 TCOF1 ZMYND8 ASH1L EYA3 WAC BICD1 CSDE1 UBE2O PTPRA MIA2 STX18 SYNJ1 TMEM131 CHD6 ANKRD36 LRBA NIPBL ARHGAP21 | 1.51e-07 | 1285 | 162 | 22 | 35914814 | |
| Pubmed | CASP8AP2 ZNF609 FNBP4 AAK1 MAML1 BCOR ANKLE2 UBE2O ZNF608 TTLL4 TET1 SLMAP ANKRD17 RPRD2 | 2.12e-07 | 529 | 162 | 14 | 14621295 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MYC RANBP2 ZNF609 RNF168 ATN1 TCOF1 RBBP6 PODXL AHCTF1 ZNF407 CLCC1 WAC HOXA1 TMX2 IGF2R MIA2 STX18 ZNF608 MKI67 TOP2A TP53BP1 | 2.16e-07 | 1203 | 162 | 21 | 29180619 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 MAP1A MAP1B ZMYND8 SSRP1 TRIM24 ADAR FANCD2 STX18 PRPF4 RGPD3 ANKRD17 LRBA NIPBL TOP2A TP53BP1 | 2.18e-07 | 704 | 162 | 16 | 29955894 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.14e-07 | 13 | 162 | 4 | 31427429 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 9480752 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | MYC TCOF1 AHCTF1 SSRP1 ADAR PRPF4 MACROH2A2 NKAP NIPBL FTSJ3 | 4.23e-07 | 259 | 162 | 10 | 30404004 |
| Pubmed | RANBP2 MAP1B TCOF1 AHCTF1 ZNF318 NUP214 CSDE1 UBE2O IGF2R MKI67 ANKRD17 NIPBL NUP153 TP53BP1 FTSJ3 | 4.64e-07 | 653 | 162 | 15 | 22586326 | |
| Pubmed | NCOA3 RANBP2 ZNF609 TCOF1 RBBP6 TNRC6B NUP214 CSDE1 FAM193A MKI67 ANKRD17 CHD6 NKAP NUP153 FTSJ3 | 4.83e-07 | 655 | 162 | 15 | 35819319 | |
| Pubmed | RANBP2 ZNF609 SCYL3 BCOR GPRIN1 ANKLE2 CDC14A CLCC1 FANCD2 IGF2R PTPRA PRPF4 MKI67 TMF1 MACROH2A2 PEAK1 TNS1 NUP153 FTSJ3 | 4.93e-07 | 1049 | 162 | 19 | 27880917 | |
| Pubmed | RANBP2 AHCTF1 NUP214 ANKLE2 CLCC1 CSDE1 STX18 RGPD3 SLMAP TMF1 TMEM131 LRBA NUP153 AHNAK2 | 4.96e-07 | 568 | 162 | 14 | 37774976 | |
| Pubmed | RGPD8 AHCTF1 NUP214 SSRP1 ADAR RGPD3 MKI67 MACROH2A2 TOP2A NUP153 FTSJ3 | 5.05e-07 | 332 | 162 | 11 | 25693804 | |
| Pubmed | RANBP2 REPS1 RBBP6 AHCTF1 ZMYND8 AAK1 MAML1 TNRC6B ZNF318 SSRP1 BCOR SCAF4 HIRA TMX2 CSDE1 SETD2 STX18 RGPD3 TMF1 ANKRD17 CHD6 NKAP NIPBL | 5.12e-07 | 1497 | 162 | 23 | 31527615 | |
| Pubmed | NCOA3 ZMYND8 EYA3 ANKLE2 WAC RAD51AP1 TET1 MKI67 RSRP1 TMEM131 TNS1 | 5.51e-07 | 335 | 162 | 11 | 15741177 | |
| Pubmed | 6.18e-07 | 152 | 162 | 8 | 38360978 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 MAP1A MAP1B TCOF1 MAP6 RBBP6 APOOL ZMYND8 FNBP4 TNRC6B SSRP1 ADAR SCAF4 HIRA SETD2 PRPF4 MACROH2A2 CHD6 NIPBL | 7.83e-07 | 1082 | 162 | 19 | 38697112 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 7.90e-07 | 157 | 162 | 8 | 30686591 | |
| Pubmed | TDRD15 TCOF1 PODXL SCYL3 MAML1 TNRC6B ZNF318 GPRIN1 CLCC1 IGF2R MKI67 TMF1 PEAK1 LRBA CLSPN ARHGAP21 | 8.02e-07 | 777 | 162 | 16 | 35844135 | |
| Pubmed | 8.32e-07 | 215 | 162 | 9 | 35973513 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 16730000 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 12138183 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7603572 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANBP2 ZNF318 NUP214 BCOR TRIM24 ADAR RGPD3 MKI67 RPRD2 CLSPN NUP153 | 1.03e-06 | 357 | 162 | 11 | 37059091 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MYC MAP1B TCOF1 RBBP6 STIL CSDE1 PTPRA SYNJ1 MKI67 RPRD2 TOP2A | 1.06e-06 | 358 | 162 | 11 | 32460013 |
| Pubmed | 1.19e-06 | 40 | 162 | 5 | 28805822 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.51e-06 | 231 | 162 | 9 | 16452087 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 ZNF609 MAP1A MAP1B AAK1 TNRC6B ADAR HIRA CSDE1 FAM193A MKI67 MARF1 ANKRD17 TMEM131 AHNAK2 | 1.67e-06 | 724 | 162 | 15 | 36232890 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA3 ZNF609 ATN1 AHCTF1 MAML1 TNRC6B NUP214 BCOR TRIM24 RGPD3 ANKRD17 NUP153 | 1.75e-06 | 457 | 162 | 12 | 32344865 |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 9259327 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYC RANBP2 MAP1B ZMYND8 MAML1 TRIM24 ADAR HIRA NFIX SLMAP ZBTB40 TMF1 ANKRD17 MACROH2A2 TOP2A TP53BP1 | 2.83e-06 | 857 | 162 | 16 | 25609649 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 TSHZ3 ZNF609 MAML1 SRF BCOR TRIM24 ZNF608 SYNJ1 NFIX NCOA1 | 2.93e-06 | 398 | 162 | 11 | 35016035 |
| Pubmed | MAP1B TCOF1 RBBP6 ZNF318 BCOR CSDE1 FSIP2 SETD2 MKI67 RPRD2 TP53BP1 | 3.00e-06 | 399 | 162 | 11 | 35987950 | |
| Pubmed | 3.11e-06 | 22 | 162 | 4 | 27717094 | ||
| Pubmed | 3.22e-06 | 86 | 162 | 6 | 37253089 | ||
| Pubmed | MYC CASP8AP2 RANBP2 HIVEP2 MAP1A RBBP6 NUP214 CSDE1 ANKRD17 CHD6 TNS1 NUP153 | 3.28e-06 | 486 | 162 | 12 | 20936779 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.42e-06 | 7 | 162 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.42e-06 | 7 | 162 | 3 | 11353387 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 30944974 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.42e-06 | 7 | 162 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.42e-06 | 7 | 162 | 3 | 17372272 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 38657106 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 21205196 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 18949001 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 25187515 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 8603673 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 26632511 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 24403063 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 23818861 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 23536549 | ||
| Pubmed | The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice. | 3.42e-06 | 7 | 162 | 3 | 28374742 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 12191015 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 22821000 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 20682751 | ||
| Pubmed | 3.43e-06 | 191 | 162 | 8 | 20195357 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 RGPD8 MAP1A TCOF1 RBBP6 MAML1 ZNF318 EYA3 BCOR SETD2 SYNJ1 CLSPN TP53BP1 | 4.22e-06 | 588 | 162 | 13 | 38580884 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.46e-06 | 8 | 162 | 3 | 21670213 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.46e-06 | 8 | 162 | 3 | 21310149 | |
| Interaction | NAA40 interactions | RANBP2 REPS1 ANK2 MAP1A MAP1B TCOF1 RBBP6 AHCTF1 ZMYND8 AAK1 TNRC6B ZNF318 NUP214 SSRP1 BCOR GPRIN1 ADAR SCAF4 WAC CSDE1 SETD2 UBE2O FAM193A SYNJ1 CLMN MKI67 ANKRD17 NCOA7 RPRD2 LRBA NIPBL ARHGAP21 TOP2A NUP153 TP53BP1 AHNAK2 FTSJ3 | 5.90e-16 | 978 | 157 | 37 | int:NAA40 |
| Interaction | NUP43 interactions | CASP8AP2 RANBP2 ZNF609 ERCC5 ATN1 RGPD8 RBBP6 AHCTF1 ZMYND8 ASH1L MUC19 TNRC6B ZNF318 NUP214 SSRP1 BCOR FANCD2 FSIP2 SETD2 ZNF608 MKI67 MARF1 CHD6 NKAP NIPBL TOP2A NUP153 AHNAK2 RGPD5 FTSJ3 | 1.03e-15 | 625 | 157 | 30 | int:NUP43 |
| Interaction | SP7 interactions | MYC NCOA3 TSHZ3 ZNF609 ATN1 RBBP6 MAML1 ZNF318 EYA3 BCOR TRIM24 SCAF4 ZNF608 ZSCAN21 NFIX NCOA1 RPRD2 N4BP1 NIPBL FILIP1L | 2.98e-13 | 304 | 157 | 20 | int:SP7 |
| Interaction | SMG7 interactions | NCOA3 TSHZ3 ZNF609 ERCC5 MAML1 TNRC6B ZNF318 STIL BCOR TRIM24 BICD1 CSDE1 UBE2O FAM193A ZNF608 TET1 NCOA1 ANKRD17 RPRD2 CLSPN | 7.31e-13 | 319 | 157 | 20 | int:SMG7 |
| Interaction | TLE3 interactions | MYC NCOA3 TSHZ3 ZNF609 HIVEP2 ATN1 RBBP6 MAML1 ZNF318 EYA3 BCOR SCAF4 WAC SETD2 FAM193A ZNF608 NFIX NCOA1 CHD6 NIPBL | 1.48e-11 | 376 | 157 | 20 | int:TLE3 |
| Interaction | KDM1A interactions | MYC KIAA0408 CASP8AP2 NCOA3 RANBP2 VPS11 TSHZ3 ZNF609 RNF168 ZMYND8 TNRC6B ZNF318 NUP214 BCOR TRIM24 HOXA1 FANCD2 FAM193A ZNF608 SYNJ1 TET1 ATF7IP2 TMF1 ANKRD17 CHD6 LRBA ARHGAP21 TP53BP1 | 8.96e-10 | 941 | 157 | 28 | int:KDM1A |
| Interaction | WWTR1 interactions | MAP1B AHCTF1 TNRC6B ZNF318 SSRP1 BCOR GPRIN1 ADAR CSDE1 SETD2 UBE2O SYNJ1 RPRD2 PEAK1 LRBA TOP2A TP53BP1 RGPD5 | 5.54e-09 | 422 | 157 | 18 | int:WWTR1 |
| Interaction | EGR2 interactions | NCOA3 ZNF609 HIVEP2 ATN1 MAML1 BCOR TRIM24 HIRA ZNF608 TET1 NCOA1 NIPBL | 9.92e-09 | 171 | 157 | 12 | int:EGR2 |
| Interaction | NUP50 interactions | MYC RANBP2 RGPD8 RBBP6 AHCTF1 FNBP4 ZNF318 NUP214 BCOR FANCD2 ZSCAN21 MARF1 RPRD2 CLSPN NUP153 TP53BP1 | 1.09e-08 | 341 | 157 | 16 | int:NUP50 |
| Interaction | PHF21A interactions | MYC CASP8AP2 RANBP2 TSHZ3 ZMYND8 TNRC6B ZNF318 NUP214 BCOR FAM193A SYNJ1 TET1 TMF1 CHD6 LRBA ARHGAP21 | 1.18e-08 | 343 | 157 | 16 | int:PHF21A |
| Interaction | SMC5 interactions | RANBP2 ZNF609 MAP1B RBBP6 AHCTF1 ZMYND8 FNBP4 ZNF318 NUP214 SSRP1 BCOR TRIM24 ADAR SCAF4 WAC RAD51AP1 SETD2 ZSCAN21 PRPF4 MKI67 MARF1 RPRD2 NIPBL TOP2A NUP153 TP53BP1 FTSJ3 | 1.47e-08 | 1000 | 157 | 27 | int:SMC5 |
| Interaction | KCNA3 interactions | RANBP2 REPS1 ANK2 MAP1B TCOF1 RBBP6 SPEF2 AHCTF1 AAK1 TNRC6B NUP214 GPRIN1 ANKLE2 CLIP1 CLCC1 CSDE1 IGF2R CCDC62 ANKRD17 RP1 PEAK1 LRBA ARHGAP21 NUP153 NLRP5 | 1.65e-08 | 871 | 157 | 25 | int:KCNA3 |
| Interaction | NXF2 interactions | 3.93e-08 | 65 | 157 | 8 | int:NXF2 | |
| Interaction | PAX7 interactions | 4.71e-08 | 124 | 157 | 10 | int:PAX7 | |
| Interaction | SUMO1 interactions | MYC CASP8AP2 NCOA3 RANBP2 RNF168 SSRP1 TRIM24 SCAF4 FANCD2 MKI67 NCOA1 TOP2A NUP153 TP53BP1 | 5.82e-08 | 287 | 157 | 14 | int:SUMO1 |
| Interaction | RCOR1 interactions | MYC CASP8AP2 RANBP2 TSHZ3 ZMYND8 TNRC6B ZNF318 BCOR FAM193A SYNJ1 TET1 MKI67 TMF1 ANKRD17 CHD6 LRBA ARHGAP21 TP53BP1 | 6.18e-08 | 494 | 157 | 18 | int:RCOR1 |
| Interaction | PML interactions | MYC CASP8AP2 RANBP2 ZNF609 REPS1 MAP1A MAP1B AAK1 SRF TNRC6B ZNF318 EYA3 BCOR TRIM24 HIRA FANCD2 CSDE1 ZNF608 ZSCAN21 PRPF4 RGPD3 MACROH2A2 TOP2A TP53BP1 AHNAK2 | 6.27e-08 | 933 | 157 | 25 | int:PML |
| Interaction | SNRNP40 interactions | MYC CASP8AP2 ZNF609 ATN1 TCOF1 RBBP6 AHCTF1 ZNF318 EYA3 SSRP1 BCOR TRIM24 SCAF4 WAC SETD2 ZNF608 PRPF4 MKI67 TOP2A FTSJ3 | 1.24e-07 | 637 | 157 | 20 | int:SNRNP40 |
| Interaction | CBX3 interactions | MYC TCOF1 RBBP6 AHCTF1 ZMYND8 SSRP1 BCOR TRIM24 WAC TGOLN2 FANCD2 RAD51AP1 SETD2 UBE2O ZSCAN21 MKI67 CLSPN NIPBL TOP2A TP53BP1 | 1.55e-07 | 646 | 157 | 20 | int:CBX3 |
| Interaction | FMR1 interactions | MYC NCOA3 RANBP2 MAP1B TCOF1 RBBP6 ZMYND8 TNRC6B ADAR FANCD2 CSDE1 MKI67 ANKRD17 TNS1 NIPBL ARHGAP21 TOP2A TP53BP1 | 2.08e-07 | 536 | 157 | 18 | int:FMR1 |
| Interaction | RNF43 interactions | RANBP2 AHCTF1 TNRC6B ZNF318 TRIM24 ANKLE2 UBE2O FAM193A MKI67 TMEM131 N4BP1 PEAK1 LRBA ARHGAP21 NUP153 AHNAK2 | 2.41e-07 | 427 | 157 | 16 | int:RNF43 |
| Interaction | TBR1 interactions | 2.51e-07 | 113 | 157 | 9 | int:TBR1 | |
| Interaction | TBXT interactions | 3.15e-07 | 116 | 157 | 9 | int:TBXT | |
| Interaction | PPIA interactions | MYC ZNF609 REPS1 MAP1A MAP1B SPEF2 ZMYND8 TNRC6B EYA3 ADAR CLIP1 CEP43 SCAF4 FANCD2 CSDE1 IGF2R MKI67 RPRD2 ANKRD36 ARHGAP21 TOP2A NUP153 TP53BP1 | 4.08e-07 | 888 | 157 | 23 | int:PPIA |
| Interaction | SIRT6 interactions | RANBP2 RGPD8 TCOF1 FNBP4 ZNF318 NUP214 SSRP1 BCOR ADAR WAC SETD2 MKI67 ANKRD17 RPRD2 TOP2A NUP153 TP53BP1 RGPD5 FTSJ3 | 4.62e-07 | 628 | 157 | 19 | int:SIRT6 |
| Interaction | RGPD4 interactions | 6.37e-07 | 22 | 157 | 5 | int:RGPD4 | |
| Interaction | PAX9 interactions | 8.28e-07 | 130 | 157 | 9 | int:PAX9 | |
| Interaction | NUP35 interactions | NCOA3 RANBP2 ZNF609 ATN1 AHCTF1 MAML1 TNRC6B NUP214 BCOR TRIM24 TGOLN2 HIVEP3 RGPD3 ANKRD17 NUP153 | 1.20e-06 | 424 | 157 | 15 | int:NUP35 |
| Interaction | TERF2IP interactions | MYC ZNF609 ERCC5 RBBP6 AHCTF1 ZMYND8 ZNF318 EYA3 SSRP1 BCOR TRIM24 SETD2 ZNF608 MKI67 CLSPN NIPBL TOP2A | 1.52e-06 | 552 | 157 | 17 | int:TERF2IP |
| Interaction | PIP interactions | MYC RANBP2 REPS1 BCOR TRIM24 ANKLE2 CEP43 FANCD2 UBE2O SLMAP | 1.60e-06 | 181 | 157 | 10 | int:PIP |
| Interaction | RGPD3 interactions | 1.68e-06 | 47 | 157 | 6 | int:RGPD3 | |
| Interaction | SSRP1 interactions | MYC RANBP2 RBBP6 ZMYND8 SRF SSRP1 TRIM24 ADAR SCAF4 FANCD2 CSDE1 SETD2 UBE2O PRPF4 RPRD2 MACROH2A2 CLSPN NIPBL TOP2A | 1.69e-06 | 685 | 157 | 19 | int:SSRP1 |
| Interaction | SYNE3 interactions | RANBP2 TNRC6B ZNF318 NUP214 STIL ANKLE2 CEP43 CLCC1 IGF2R FAM193A MIA2 CLMN SLMAP TMEM131 ARHGAP21 | 2.12e-06 | 444 | 157 | 15 | int:SYNE3 |
| Interaction | STX6 interactions | VPS11 SCYL3 GPRIN1 ANKLE2 CLCC1 TGOLN2 IGF2R STX18 SYNJ1 TMF1 NCOA7 PEAK1 LRBA ARHGAP21 AHNAK2 | 2.36e-06 | 448 | 157 | 15 | int:STX6 |
| Interaction | SOX7 interactions | 3.55e-06 | 82 | 157 | 7 | int:SOX7 | |
| Interaction | CEBPA interactions | MYC RPGRIP1 NCOA3 RANBP2 ZNF609 ZMYND8 MAML1 ZNF318 EYA3 SSRP1 BCOR TRIM24 ADAR SCAF4 WAC CSDE1 ZSCAN21 PRPF4 MKI67 ZBTB40 NCOA1 NIPBL TOP2A NUP153 TP53BP1 FTSJ3 | 3.84e-06 | 1245 | 157 | 26 | int:CEBPA |
| Interaction | NUMA1 interactions | MYC RANBP2 AHCTF1 NUP214 ADAR FANCD2 CSDE1 BRDT LRRC31 RGPD3 MKI67 MACROH2A2 TOP2A NUP153 TP53BP1 | 4.13e-06 | 469 | 157 | 15 | int:NUMA1 |
| Interaction | RANBP2 interactions | MYC RANBP2 RGPD8 NUP214 SSRP1 ADAR CLIP1 BICD1 FANCD2 RGPD3 TOP2A NUP153 RGPD5 | 5.25e-06 | 361 | 157 | 13 | int:RANBP2 |
| Interaction | NFIC interactions | MYC NCOA3 ZNF609 BCOR TRIM24 ZNF608 NFIX MKI67 PLCB3 TP53BP1 | 6.03e-06 | 210 | 157 | 10 | int:NFIC |
| Interaction | PAX6 interactions | NCOA3 TSHZ3 ZNF609 DRGX CINP BCOR TRIM24 HOXA1 ZNF608 SYNJ1 NFIX CHD6 NIPBL | 6.09e-06 | 366 | 157 | 13 | int:PAX6 |
| Interaction | RHBDF2 interactions | 6.91e-06 | 168 | 157 | 9 | int:RHBDF2 | |
| Interaction | SLFN11 interactions | RANBP2 RNF168 MAP1B RBBP6 NUP214 CEP43 SETD2 PRPF4 MKI67 TOP2A NUP153 TP53BP1 FTSJ3 | 8.14e-06 | 376 | 157 | 13 | int:SLFN11 |
| Interaction | H2BC21 interactions | MYC CYLC1 RNF168 MAP1B AHCTF1 ZMYND8 FNBP4 SSRP1 BCOR TRIM24 SCAF4 HIRA TET1 MKI67 RPRD2 MACROH2A2 NIPBL TOP2A | 8.45e-06 | 696 | 157 | 18 | int:H2BC21 |
| Interaction | AR interactions | MYC NCOA3 DCAF6 ZNF609 ATN1 ZMYND8 MAML1 ZNF318 SSRP1 BCOR TRIM24 ADAR HIRA WAC ZNF608 ZSCAN21 NFIX TMF1 NCOA1 RPRD2 TNS1 NIPBL | 9.23e-06 | 992 | 157 | 22 | int:AR |
| Interaction | NUP107 interactions | MYC RANBP2 RGPD8 AHCTF1 NUP214 CLIP1 FANCD2 LRRC31 NUP153 TP53BP1 | 9.44e-06 | 221 | 157 | 10 | int:NUP107 |
| Interaction | TLX1 interactions | 9.61e-06 | 175 | 157 | 9 | int:TLX1 | |
| Interaction | NPIPB6 interactions | 9.96e-06 | 18 | 157 | 4 | int:NPIPB6 | |
| Interaction | SLX4 interactions | RANBP2 MAML1 ZNF318 NUP214 BCOR TRIM24 ADAR FANCD2 PRPF4 RGPD3 MKI67 RPRD2 CLSPN NIPBL NUP153 TP53BP1 | 1.06e-05 | 572 | 157 | 16 | int:SLX4 |
| Interaction | XRCC6 interactions | MYC KIAA0408 MAP1B RBBP6 AHCTF1 ZMYND8 ZNF318 SSRP1 TRIM24 ADAR WAC FANCD2 CSDE1 UBE2O LRRC31 MKI67 RPRD2 MACROH2A2 TOP2A NUP153 TP53BP1 | 1.11e-05 | 928 | 157 | 21 | int:XRCC6 |
| Interaction | NLE1 interactions | MYC TCOF1 RBBP6 SSRP1 FANCD2 SETD2 MKI67 MACROH2A2 CLSPN TOP2A | 1.24e-05 | 228 | 157 | 10 | int:NLE1 |
| Interaction | CSNK2A2 interactions | MYC ERCC5 TCOF1 ZMYND8 ASH1L SRF SSRP1 BCOR ANKRD36B UBE2O BRDT PRPF4 MKI67 ANKRD36 NKAP TOP2A TP53BP1 AHNAK2 | 1.29e-05 | 718 | 157 | 18 | int:CSNK2A2 |
| Interaction | ALG13 interactions | 1.38e-05 | 183 | 157 | 9 | int:ALG13 | |
| Interaction | ADAR interactions | MYC RANBP2 ZNF318 NUP214 SSRP1 ADAR FANCD2 MKI67 NIPBL TOP2A FTSJ3 | 1.55e-05 | 286 | 157 | 11 | int:ADAR |
| Interaction | MEN1 interactions | MYC ZNF609 ATN1 TCOF1 RBBP6 AHCTF1 ZMYND8 FNBP4 SSRP1 ARHGEF17 ADAR HIRA WAC FANCD2 ZNF608 PRPF4 MKI67 ANKRD17 TOP2A NUP153 TP53BP1 FTSJ3 | 1.63e-05 | 1029 | 157 | 22 | int:MEN1 |
| Interaction | HDAC1 interactions | MYC CASP8AP2 RANBP2 TSHZ3 ZNF609 ZMYND8 TNRC6B ZNF318 NUP214 BCOR FANCD2 ZNF608 SYNJ1 NFIX TET1 MKI67 TMF1 ANKRD17 AFF1 LRBA ARHGAP21 TOP2A FTSJ3 | 1.64e-05 | 1108 | 157 | 23 | int:HDAC1 |
| Interaction | KANSL2 interactions | 1.77e-05 | 70 | 157 | 6 | int:KANSL2 | |
| Interaction | TLX3 interactions | NCOA3 ZNF609 MAML1 EYA3 BCOR TRIM24 ZNF608 NFIX CHD6 NIPBL TP53BP1 | 1.82e-05 | 291 | 157 | 11 | int:TLX3 |
| Interaction | HNF1B interactions | 1.86e-05 | 190 | 157 | 9 | int:HNF1B | |
| Interaction | FAM193A interactions | 1.92e-05 | 71 | 157 | 6 | int:FAM193A | |
| Interaction | MYOD1 interactions | 2.19e-05 | 194 | 157 | 9 | int:MYOD1 | |
| Interaction | B9D2 interactions | 2.25e-05 | 73 | 157 | 6 | int:B9D2 | |
| Interaction | YTHDF3 interactions | MYC TNRC6B STIL TGOLN2 CSDE1 FAM193A MKI67 MARF1 ANKRD17 TOP2A | 2.39e-05 | 246 | 157 | 10 | int:YTHDF3 |
| Interaction | RGPD8 interactions | 2.43e-05 | 74 | 157 | 6 | int:RGPD8 | |
| Interaction | SMC1A interactions | MYC TRIM24 ADAR CDC14A TGOLN2 FANCD2 ZNF608 NFIX MKI67 ANKRD17 MACROH2A2 NIPBL TP53BP1 | 2.49e-05 | 418 | 157 | 13 | int:SMC1A |
| Interaction | SNRPA interactions | MYC MAP1B RBBP6 ZNF318 SSRP1 TRIM24 ADAR SCAF4 FANCD2 SETD2 PRPF4 RPRD2 NKAP TOP2A | 2.56e-05 | 482 | 157 | 14 | int:SNRPA |
| Interaction | PAX8 interactions | 2.63e-05 | 111 | 157 | 7 | int:PAX8 | |
| Interaction | DHX40 interactions | 2.65e-05 | 249 | 157 | 10 | int:DHX40 | |
| Interaction | EZR interactions | VPS11 REPS1 ANK2 PODXL SCYL3 DNAAF11 GPRIN1 FANCD2 SYNJ1 ATF7IP2 PLCB3 PEAK1 LRBA ARHGAP21 FTSJ3 | 2.89e-05 | 553 | 157 | 15 | int:EZR |
| Interaction | TNPO1 interactions | MYC RANBP2 MAP1B NUP214 STIL CLIP1 UBE2O PTPRA SUCO NUP153 RGPD5 | 2.90e-05 | 306 | 157 | 11 | int:TNPO1 |
| Interaction | BAG2 interactions | MYC ZNF609 MAP1B FNBP4 AAK1 ZNF318 STIL EYA3 BCOR HIRA FANCD2 CSDE1 TMF1 RPRD2 ARHGAP21 NLRP5 | 2.95e-05 | 622 | 157 | 16 | int:BAG2 |
| Interaction | SYNGAP1 interactions | ANK2 MAP1A MAP1B MAP6 AAK1 GPRIN1 SYNJ1 SLMAP PEAK1 ARHGAP21 TP53BP1 | 2.99e-05 | 307 | 157 | 11 | int:SYNGAP1 |
| Interaction | FEV interactions | 3.13e-05 | 203 | 157 | 9 | int:FEV | |
| Interaction | SPOP interactions | MYC NCOA3 TCOF1 APOOL ZMYND8 TRIM24 TMX2 SETD2 UBE2O PRPF4 RGPD3 RPRD2 NUP153 TP53BP1 | 3.14e-05 | 491 | 157 | 14 | int:SPOP |
| Interaction | TOP1 interactions | MYC TCOF1 RBBP6 ZMYND8 SSRP1 TRIM24 ADAR SCAF4 FANCD2 SETD2 UBE2O PRPF4 MKI67 RPRD2 MACROH2A2 NIPBL TOP2A | 3.16e-05 | 696 | 157 | 17 | int:TOP1 |
| Interaction | DDB1 interactions | MYC DCAF6 MAP1B ZMYND8 IP6K1 SSRP1 BCOR CEP43 TGOLN2 FANCD2 CSDE1 SETD2 UBE2O PRPF4 TET1 MACROH2A2 FTSJ3 | 3.22e-05 | 697 | 157 | 17 | int:DDB1 |
| Interaction | H3C3 interactions | TSHZ3 RNF168 AHCTF1 EYA3 SSRP1 TRIM24 HIRA FSIP2 UBE2O ZSCAN21 MKI67 CHD6 NIPBL TOP2A | 3.43e-05 | 495 | 157 | 14 | int:H3C3 |
| Interaction | CNOT3 interactions | 3.65e-05 | 207 | 157 | 9 | int:CNOT3 | |
| Interaction | SEC24C interactions | 3.65e-05 | 207 | 157 | 9 | int:SEC24C | |
| Interaction | BRCA1 interactions | MYC RPGRIP1 NCOA3 ERCC5 RNF168 TCOF1 FNBP4 TNRC6B NUP214 SSRP1 TRIM24 CLIP1 CEP43 FANCD2 CSDE1 ZSCAN21 MKI67 NCOA1 CLSPN NIPBL ARHGAP21 TOP2A NUP153 TP53BP1 | 3.70e-05 | 1249 | 157 | 24 | int:BRCA1 |
| Interaction | CPNE4 interactions | 3.89e-05 | 49 | 157 | 5 | int:CPNE4 | |
| Interaction | SOX5 interactions | 4.06e-05 | 162 | 157 | 8 | int:SOX5 | |
| Interaction | H2BC13 interactions | 4.08e-05 | 210 | 157 | 9 | int:H2BC13 | |
| Interaction | H2BC8 interactions | ERCC5 AHCTF1 ZMYND8 SSRP1 BCOR TRIM24 RAD51AP1 UBE2O ZSCAN21 PRPF4 MKI67 MACROH2A2 CHD6 NIPBL TOP2A | 4.60e-05 | 576 | 157 | 15 | int:H2BC8 |
| Interaction | PFN1 interactions | MYC RANBP2 ANK2 MAP1A AAK1 TRIM24 FANCD2 SYNJ1 SLMAP TMF1 PEAK1 ARHGAP21 TP53BP1 AHNAK2 | 4.64e-05 | 509 | 157 | 14 | int:PFN1 |
| Interaction | BRCA2 interactions | ERCC5 RNF168 SSRP1 FANCD2 RAD51AP1 MKI67 RPRD2 CLSPN PRG4 NIPBL TOP2A TP53BP1 | 4.92e-05 | 384 | 157 | 12 | int:BRCA2 |
| Interaction | TRAF3IP3 interactions | 5.00e-05 | 84 | 157 | 6 | int:TRAF3IP3 | |
| Interaction | PIP4K2A interactions | 5.08e-05 | 216 | 157 | 9 | int:PIP4K2A | |
| Interaction | RGPD2 interactions | 5.41e-05 | 27 | 157 | 4 | int:RGPD2 | |
| Interaction | RPA4 interactions | RANBP2 TSHZ3 ERCC5 TCOF1 AHCTF1 NUP214 SSRP1 CSDE1 SETD2 MKI67 RPRD2 TOP2A NUP153 | 5.56e-05 | 452 | 157 | 13 | int:RPA4 |
| Interaction | NUP62 interactions | MYC RANBP2 RGPD8 NUP214 TRIM24 CLIP1 RGPD3 ATF7IP2 NUP153 RGPD5 | 5.76e-05 | 273 | 157 | 10 | int:NUP62 |
| Interaction | SUMO2 interactions | MYC CASP8AP2 RANBP2 RNF168 ZMYND8 NUP214 SSRP1 TRIM24 FANCD2 MKI67 NIPBL TOP2A NUP153 TP53BP1 AHNAK2 | 6.15e-05 | 591 | 157 | 15 | int:SUMO2 |
| Interaction | TUBA8 interactions | 6.93e-05 | 89 | 157 | 6 | int:TUBA8 | |
| Interaction | KIF20A interactions | MYC RANBP2 ANK2 RGPD8 RBBP6 AHCTF1 TNRC6B ZNF318 SSRP1 ADAR CDC14A MLIP MIA2 PRPF4 RGPD3 MKI67 AFF1 MACROH2A2 TOP2A AHNAK2 FTSJ3 | 6.97e-05 | 1052 | 157 | 21 | int:KIF20A |
| Interaction | TNRC6A interactions | TNRC6B STIL TRIM24 BICD1 UBE2O FAM193A MARF1 ANKRD17 TP53BP1 AHNAK2 | 7.11e-05 | 280 | 157 | 10 | int:TNRC6A |
| Interaction | TEAD1 interactions | 7.30e-05 | 176 | 157 | 8 | int:TEAD1 | |
| Interaction | NFIX interactions | 7.45e-05 | 227 | 157 | 9 | int:NFIX | |
| Interaction | TNRC6B interactions | MYC RPGRIP1 TNRC6B STIL TRIM24 BICD1 CSDE1 FAM193A MARF1 ANKRD17 | 7.54e-05 | 282 | 157 | 10 | int:TNRC6B |
| Interaction | RHBDD1 interactions | RANBP2 IP6K1 NUP214 ANKLE2 CLCC1 TGOLN2 CSDE1 IGF2R CLMN MKI67 NUP153 | 8.77e-05 | 346 | 157 | 11 | int:RHBDD1 |
| Interaction | S100A6 interactions | 9.09e-05 | 233 | 157 | 9 | int:S100A6 | |
| Interaction | KLF15 interactions | NCOA3 TSHZ3 ZNF609 MAML1 BCOR TRIM24 ZNF608 NCOA1 NIPBL FTSJ3 | 9.51e-05 | 290 | 157 | 10 | int:KLF15 |
| GeneFamily | Nucleoporins | 2.11e-05 | 32 | 93 | 4 | 1051 | |
| GeneFamily | Ankyrin repeat domain containing | 2.52e-04 | 242 | 93 | 7 | 403 | |
| GeneFamily | Transmembrane channel likes | 7.18e-04 | 8 | 93 | 2 | 1135 | |
| GeneFamily | PHD finger proteins | 1.20e-03 | 90 | 93 | 4 | 88 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.94e-03 | 115 | 93 | 4 | 769 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.39e-03 | 17 | 93 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | TSHZ3 ZNF609 HIVEP2 ZNF407 ZNF318 HIVEP3 ZNF530 ZNF608 ZSCAN21 ZBTB40 | 3.80e-03 | 718 | 93 | 10 | 28 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC NCOA3 RANBP2 HIVEP2 MAP1B PODXL AHCTF1 ZMYND8 STIL TRIM24 ANKLE2 CLIP1 HIRA BICD1 SETD2 IGF2R PTPRA FAM193A MIA2 NCOA1 ANKRD17 AFF1 TMEM131 N4BP1 SUCO NIPBL TOP2A NUP153 TP53BP1 FILIP1L | 7.80e-15 | 856 | 160 | 30 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYC NCOA3 HIVEP2 MAP1B ZMYND8 STIL CLIP1 HIRA SETD2 PTPRA MARF1 NCOA1 ANKRD17 AFF1 TMEM131 TOP2A NUP153 FILIP1L | 6.11e-10 | 466 | 160 | 18 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 RANBP2 VPS11 ZNF609 HIVEP2 RBBP6 SPEF2 PARP8 ASH1L FNBP4 AAK1 TNRC6B ANKLE2 ADAR CLIP1 CDC14A WAC TGOLN2 CSDE1 HIVEP3 SETD2 PTPRA TBC1D1 TMF1 NCOA1 N4BP1 LRBA NIPBL NUP153 | 2.75e-08 | 1492 | 160 | 29 | M40023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | MYC NCOA3 HIVEP2 ZMYND8 MAML1 ZNF318 MKI67 AFF1 N4BP1 SUCO TOP2A NUP153 | 3.46e-07 | 300 | 160 | 12 | M8702 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RANBP2 HIVEP2 RGPD8 PARP8 FNBP4 PRPF4 TBC1D1 NFIX RGPD3 NCOA7 AFF1 N4BP1 FILIP1L | 2.92e-06 | 435 | 160 | 13 | MM1221 |
| Coexpression | FISCHER_DREAM_TARGETS | MYC CASP8AP2 TCOF1 RBBP6 AHCTF1 FNBP4 STIL SSRP1 FANCD2 RAD51AP1 ZNF530 PRPF4 TTLL4 MKI67 ANKRD17 CLSPN NIPBL TOP2A NUP153 | 7.73e-06 | 969 | 160 | 19 | M149 |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | NCOA3 MAP1B PODXL ZMYND8 MAML1 SRF N4BP1 LRBA NUP153 FILIP1L | 1.21e-05 | 289 | 160 | 10 | M13630 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 ERCC5 PODXL AHCTF1 ZNF407 TRIM24 CLIP1 RAD51AP1 PRPF4 SLMAP MKI67 TMF1 NKAP SUCO NIPBL | 1.27e-05 | 656 | 160 | 15 | M18979 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | NCOA3 APOOL SCYL3 AAK1 TNRC6B NUP214 CLIP1 SCAF4 IGF2R MIA2 SYNJ1 NCOA1 RSRP1 N4BP1 CHD6 FILIP1L | 2.38e-05 | 778 | 160 | 16 | M17915 |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 2.97e-05 | 197 | 160 | 8 | M3133 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP | 3.08e-05 | 198 | 160 | 8 | M3129 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 3.19e-05 | 199 | 160 | 8 | M5799 | |
| Coexpression | GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP | 3.31e-05 | 200 | 160 | 8 | M7073 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP | 3.31e-05 | 200 | 160 | 8 | M3832 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 3.31e-05 | 200 | 160 | 8 | M9260 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RANBP2 RGPD8 RBBP6 AHCTF1 APOOL FNBP4 ZNF318 ANKLE2 SCAF4 RGPD3 RSRP1 RGPD5 | 3.67e-05 | 474 | 160 | 12 | M40991 |
| Coexpression | BURTON_ADIPOGENESIS_12 | 4.21e-05 | 32 | 160 | 4 | M1558 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 4.21e-05 | 32 | 160 | 4 | MM668 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.24e-05 | 157 | 160 | 7 | M7733 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RANBP2 HIVEP2 PARP8 FNBP4 PRPF4 TBC1D1 NFIX NCOA7 AFF1 N4BP1 FILIP1L | 5.52e-05 | 418 | 160 | 11 | M12676 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NCOA3 RANBP2 TSHZ3 HIVEP2 MAP1A MAP1B MAP6 AHCTF1 ASH1L ZNF318 CLIP1 WAC TGOLN2 CSDE1 AFF1 SUCO TNS1 | 7.08e-05 | 946 | 160 | 17 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 8.34e-05 | 169 | 160 | 7 | M39230 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.42e-04 | 184 | 160 | 7 | M19988 | |
| Coexpression | PARK_HSC_MARKERS | 1.50e-04 | 44 | 160 | 4 | M6509 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | VPS11 ZNF609 RBBP6 APOOL SCYL3 ZMYND8 CLIP1 WAC RAD51AP1 STX18 PRPF4 TBC1D1 ANKRD17 AFF1 RSRP1 TMEM131 N4BP1 LRBA NIPBL | 1.63e-04 | 1215 | 160 | 19 | M41122 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.74e-04 | 323 | 160 | 9 | M9150 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | NCOA3 RANBP2 ERCC5 ZMYND8 SRF CLIP1 MIA2 PRPF4 AFF1 TOP2A TP53BP1 | 1.89e-04 | 481 | 160 | 11 | M3898 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | NCOA3 MAP1B RBBP6 PODXL SPEF2 PARP8 FNBP4 ANKRD30B ADAR HIRA HIVEP3 KCNB1 NCOA7 TMEM131 ARHGAP21 TMEM117 AHNAK2 | 2.03e-04 | 1033 | 160 | 17 | M4196 |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN | 2.09e-04 | 196 | 160 | 7 | M8678 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.09e-04 | 196 | 160 | 7 | M4244 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 2.29e-04 | 199 | 160 | 7 | M9964 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP | 2.29e-04 | 199 | 160 | 7 | M8748 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 2.36e-04 | 200 | 160 | 7 | M3508 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 2.36e-04 | 200 | 160 | 7 | M8620 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN | 2.36e-04 | 200 | 160 | 7 | M8781 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP | 2.36e-04 | 200 | 160 | 7 | M7442 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.36e-04 | 200 | 160 | 7 | M7431 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 2.36e-04 | 200 | 160 | 7 | M5069 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 2.36e-04 | 200 | 160 | 7 | M2936 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | 2.36e-04 | 200 | 160 | 7 | M9083 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 2.36e-04 | 200 | 160 | 7 | M9277 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP | 2.36e-04 | 200 | 160 | 7 | M4347 | |
| Coexpression | GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.36e-04 | 200 | 160 | 7 | M6983 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | MYC HIVEP2 TCOF1 RBBP6 POLR3H APOOL NUP214 CEP43 HIVEP3 ZNF530 TBC1D1 TET1 ATF7IP2 TMF1 NCOA1 ANKRD36 | 2.43e-04 | 950 | 160 | 16 | M19907 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 3.07e-04 | 276 | 160 | 8 | M3063 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MYC ERCC5 TCOF1 RBBP6 SCYL3 FNBP4 ZNF318 NUP214 ADAR CDC14A HIRA TGOLN2 RAD51AP1 KCNB1 PRPF4 MKI67 RSRP1 NXPH2 TOP2A NUP153 | 3.36e-04 | 1394 | 160 | 20 | M9585 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.36e-04 | 212 | 160 | 7 | M39221 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | RANBP2 ZNF609 RGPD8 RBBP6 PARP8 AAK1 OSER1 CDC14A NUP153 RGPD5 | 3.38e-04 | 432 | 160 | 10 | M41149 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 POLR3H ANKLE2 CEP43 ERCC6L2 RPRD2 LRBA TOP2A TP53BP1 TMEM117 | 3.50e-04 | 434 | 160 | 10 | M15150 |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 3.51e-04 | 152 | 160 | 6 | M2938 | |
| Coexpression | EIF4E_DN | 3.76e-04 | 100 | 160 | 5 | M2790 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | REPS1 RNF168 ASH1L CLIP1 CLCC1 WAC NFIX MKI67 N4BP1 PEAK1 LRBA CLSPN NIPBL FILIP1L | 2.63e-08 | 291 | 153 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA3 REPS1 RNF168 ATN1 RBBP6 SCYL3 ASH1L TNRC6B CLIP1 CLCC1 WAC SETD2 FAM193A NFIX TET1 MKI67 ERCC6L2 MARF1 N4BP1 NKAP CLSPN NIPBL | 4.52e-08 | 780 | 153 | 22 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | REPS1 RNF168 PHF24 TRIM24 CLIP1 WAC TET1 SLMAP MKI67 TMEM131 N4BP1 PEAK1 LRBA CLSPN NIPBL FILIP1L | 9.80e-08 | 432 | 153 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 RANBP2 RNF168 RBBP6 CLIP1 CLCC1 FAM193A SLMAP MKI67 LRBA CLSPN NIPBL ARHGAP21 | 4.25e-07 | 311 | 153 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 ERCC5 RNF168 ANK2 LRRN1 TCOF1 RBBP6 AHCTF1 STIL TRIM24 CLIP1 CDC14A WAC BICD1 FANCD2 RAD51AP1 FAM193A TET1 SLMAP MKI67 CLSPN NIPBL ARHGAP21 TOP2A TP53BP1 FTSJ3 | 1.07e-06 | 1257 | 153 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | REPS1 RNF168 LRRN1 MAP1B ZNF407 SSRP1 TRIM24 CLIP1 WAC BICD1 UBE2O SLMAP MKI67 RPRD2 N4BP1 CLSPN TOP2A | 1.46e-06 | 595 | 153 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 ERCC5 RNF168 ANK2 LRRN1 MAP1B TCOF1 MAP6 RBBP6 AHCTF1 STIL TRIM24 CLIP1 CDC14A WAC BICD1 FANCD2 RAD51AP1 FAM193A TET1 SLMAP MKI67 CLSPN NIPBL ARHGAP21 TOP2A TP53BP1 FTSJ3 | 1.70e-06 | 1459 | 153 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 RANBP2 RNF168 ATN1 LRRN1 MAP1B RBBP6 SCYL3 ASH1L TNRC6B CLIP1 CLCC1 SETD2 FAM193A MKI67 ERCC6L2 NKAP CLSPN NIPBL ARHGAP21 | 2.32e-06 | 831 | 153 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 ZNF609 ANK2 LRRN1 MAP1A MAP1B MAP6 PARP8 STIL CINP BCOR TRIM24 CLIP1 CDC14A WAC BICD1 RAD51AP1 SYNJ1 TTLL4 MKI67 CLSPN NIPBL ARHGAP21 TOP2A TP53BP1 KCNH5 | 5.18e-06 | 1370 | 153 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.09e-05 | 192 | 153 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | REPS1 RNF168 LRRN1 ZNF407 TRIM24 CLIP1 WAC UBE2O NFIX TET1 SLMAP MKI67 TMEM131 N4BP1 CLSPN NIPBL | 1.30e-05 | 629 | 153 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 ANK2 LRRN1 MAP1A MAP1B PODXL STIL TRIM24 CLIP1 CDC14A WAC BICD1 FANCD2 RAD51AP1 TTLL4 SLMAP MKI67 CLSPN NIPBL TP53BP1 FTSJ3 | 2.49e-05 | 1060 | 153 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CASP8AP2 RANBP2 RNF168 LRRN1 MAP1A MAP1B TCOF1 RBBP6 CLIP1 CLCC1 SCAF4 BICD1 SETD2 FAM193A SLMAP MKI67 LRBA CLSPN NIPBL ARHGAP21 | 2.96e-05 | 989 | 153 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | REPS1 RNF168 TCOF1 PHF24 IRAK2 CINP TRIM24 CLIP1 WAC TBC1D1 TET1 SLMAP MKI67 TMEM131 N4BP1 PEAK1 LRBA CLSPN NIPBL FILIP1L | 2.96e-05 | 989 | 153 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CASP8AP2 TCOF1 PODXL AHCTF1 STIL EYA3 TRIM24 CLIP1 CDC14A WAC RAD51AP1 UBE2O MIA2 TET1 SLMAP MKI67 AFF1 TMEM131 N4BP1 LRBA CLSPN NIPBL FILIP1L | 3.25e-05 | 1252 | 153 | 23 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RANBP2 REPS1 RNF168 TRIM24 WAC RAD51AP1 TET1 TMF1 TMEM131 N4BP1 CLSPN NIPBL FTSJ3 | 3.65e-05 | 469 | 153 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.02e-05 | 185 | 153 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | REPS1 RNF168 ZNF407 TRIM24 CLIP1 WAC CSDE1 UBE2O SLMAP MKI67 ANKRD17 TMEM131 N4BP1 TOP2A | 6.03e-05 | 564 | 153 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | STIL WAC RAD51AP1 NFIX MKI67 N4BP1 PEAK1 CLSPN NIPBL FILIP1L | 6.25e-05 | 298 | 153 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | REPS1 RNF168 ASH1L IRAK2 CLIP1 CLCC1 WAC BICD1 IGF2R NFIX MKI67 RSRP1 N4BP1 PEAK1 LRBA CLSPN TNS1 NIPBL FILIP1L | 8.91e-05 | 985 | 153 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CASP8AP2 ANK2 LRRN1 MAP1A MAP1B MAP6 PODXL STIL TRIM24 CLIP1 CDC14A WAC BICD1 FANCD2 RAD51AP1 TTLL4 SLMAP MKI67 CLSPN NIPBL TP53BP1 KCNH5 FTSJ3 | 2.02e-04 | 1414 | 153 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | REPS1 RNF168 IRAK2 CLIP1 WAC NFIX MKI67 N4BP1 PEAK1 CLSPN NIPBL FILIP1L | 2.41e-04 | 492 | 153 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIAA0408 NCOA3 LRRN1 MAP1B APOOL ASH1L FNBP4 TRIM24 CDC14A HOXA1 CLMN TET1 N4BP1 TOP2A NUP153 FTSJ3 | 2.72e-04 | 815 | 153 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.23e-04 | 246 | 153 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 4.80e-04 | 137 | 153 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.14e-04 | 91 | 153 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RANBP2 AHCTF1 ASH1L TNRC6B ZNF407 CDC14A IGF2R RSRP1 TMEM131 ANKRD36 LRBA SUCO NIPBL TP53BP1 | 8.19e-15 | 188 | 160 | 14 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | RANBP2 PARP8 ASH1L AAK1 TNRC6B CDC14A ANKRD36B RSRP1 ANKRD36 LRBA | 1.17e-09 | 181 | 160 | 10 | f2315414e714ac86211546a935660c4be6e85f1b |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 7.70e-09 | 162 | 160 | 9 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.36e-08 | 192 | 160 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.84e-08 | 195 | 160 | 9 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-07 | 197 | 160 | 8 | 5593721407f61fc5bc3f2f8bf8fa2604c4e29565 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.39e-07 | 199 | 160 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-07 | 199 | 160 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.27e-06 | 151 | 160 | 7 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.57e-06 | 156 | 160 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 165 | 160 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 169 | 160 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.40e-06 | 113 | 160 | 6 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.40e-06 | 113 | 160 | 6 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.40e-06 | 113 | 160 | 6 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 179 | 160 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-06 | 181 | 160 | 7 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 185 | 160 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.00e-06 | 191 | 160 | 7 | 73b15ffa60d592c43aaa575f1b1479d49a66dfe8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.21e-06 | 192 | 160 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.21e-06 | 192 | 160 | 7 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 194 | 160 | 7 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-06 | 195 | 160 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-06 | 195 | 160 | 7 | b25c534fc6320d4da6437ef1b27e32a5d5256f3e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-06 | 197 | 160 | 7 | 8951787ed1f7ac1772a6ef0ba2dd44c51fd3c47b | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 7.35e-06 | 197 | 160 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-06 | 198 | 160 | 7 | 6483d412b6c0aab58b3348f99231caa5daf65025 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.85e-06 | 199 | 160 | 7 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.85e-06 | 199 | 160 | 7 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.85e-06 | 199 | 160 | 7 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 7.85e-06 | 199 | 160 | 7 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 7.85e-06 | 199 | 160 | 7 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 7.85e-06 | 199 | 160 | 7 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 7.85e-06 | 199 | 160 | 7 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.85e-06 | 199 | 160 | 7 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.85e-06 | 199 | 160 | 7 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.85e-06 | 199 | 160 | 7 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.85e-06 | 199 | 160 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.11e-06 | 200 | 160 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.11e-06 | 200 | 160 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.08e-06 | 134 | 160 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-05 | 154 | 160 | 6 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 163 | 160 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 167 | 160 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-05 | 167 | 160 | 6 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 167 | 160 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-05 | 167 | 160 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 168 | 160 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 169 | 160 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 169 | 160 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.38e-05 | 169 | 160 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.61e-05 | 171 | 160 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 3.85e-05 | 173 | 160 | 6 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 3.85e-05 | 173 | 160 | 6 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-05 | 173 | 160 | 6 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-05 | 173 | 160 | 6 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-05 | 174 | 160 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 177 | 160 | 6 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 177 | 160 | 6 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.51e-05 | 178 | 160 | 6 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 179 | 160 | 6 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.80e-05 | 180 | 160 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-05 | 180 | 160 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 180 | 160 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 180 | 160 | 6 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-05 | 181 | 160 | 6 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-05 | 181 | 160 | 6 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.26e-05 | 183 | 160 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.26e-05 | 183 | 160 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-05 | 183 | 160 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 185 | 160 | 6 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.59e-05 | 185 | 160 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 185 | 160 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 5.59e-05 | 185 | 160 | 6 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 185 | 160 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 5.59e-05 | 185 | 160 | 6 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 186 | 160 | 6 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.76e-05 | 186 | 160 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.76e-05 | 186 | 160 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 186 | 160 | 6 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 187 | 160 | 6 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 187 | 160 | 6 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 187 | 160 | 6 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 6.11e-05 | 188 | 160 | 6 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 188 | 160 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.11e-05 | 188 | 160 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 188 | 160 | 6 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 188 | 160 | 6 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.29e-05 | 189 | 160 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 6.48e-05 | 190 | 160 | 6 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.48e-05 | 190 | 160 | 6 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.48e-05 | 190 | 160 | 6 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.48e-05 | 190 | 160 | 6 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.48e-05 | 190 | 160 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 8.19e-07 | 192 | 155 | 10 | 1599_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.12e-06 | 180 | 155 | 9 | 4541_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 6347_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.30e-06 | 199 | 155 | 9 | 7148_DN | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HG-U133A | 9.30e-06 | 199 | 155 | 9 | 1936_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 3.48e-05 | 181 | 155 | 8 | 1791_DN | |
| Drug | CPG-oligonucleotide | 3.91e-05 | 184 | 155 | 8 | ctd:C408982 | |
| Drug | trimethyl(pentafluoroethyl)silane | 4.60e-05 | 2 | 155 | 2 | CID002760820 | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 5.89e-05 | 195 | 155 | 8 | 1138_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; HL60; HG-U133A | 6.11e-05 | 196 | 155 | 8 | 1995_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 6.11e-05 | 196 | 155 | 8 | 990_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A | 6.11e-05 | 196 | 155 | 8 | 1968_UP | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; HL60; HG-U133A | 6.11e-05 | 196 | 155 | 8 | 1964_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 6692_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 4802_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 3743_DN | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 1675_UP | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; HL60; HG-U133A | 6.33e-05 | 197 | 155 | 8 | 2003_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2362_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 3017_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 4383_DN | |
| Drug | colchicine; Up 200; 0.1uM; MCF7; HG-U133A | 7.04e-05 | 200 | 155 | 8 | 644_UP | |
| Disease | Prostatic Neoplasms | MYC NCOA3 DCAF6 PODXL ASH1L WAC SETD2 IGF2R TMF1 NCOA1 NCOA7 RPRD2 CHD6 TOP2A | 5.02e-06 | 616 | 155 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | MYC NCOA3 DCAF6 PODXL ASH1L WAC SETD2 IGF2R TMF1 NCOA1 NCOA7 RPRD2 CHD6 TOP2A | 5.02e-06 | 616 | 155 | 14 | C0376358 |
| Disease | Neurodevelopmental Disorders | 9.97e-06 | 93 | 155 | 6 | C1535926 | |
| Disease | Malignant neoplasm of breast | NCOA3 ANK2 ZNF318 NUP214 ADAR CLIP1 FSCB SETD2 MIA2 MKI67 NCOA1 AFF1 LRBA CLSPN TNS1 NIPBL TOP2A TP53BP1 | 1.48e-05 | 1074 | 155 | 18 | C0006142 |
| Disease | triglycerides in large LDL measurement | 7.71e-05 | 43 | 155 | 4 | EFO_0022319 | |
| Disease | leiomyoma (implicated_via_orthology) | 8.20e-05 | 3 | 155 | 2 | DOID:127 (implicated_via_orthology) | |
| Disease | Atypical juvenile parkinsonism | 8.20e-05 | 3 | 155 | 2 | C4510873 | |
| Disease | Intellectual Disability | 1.34e-04 | 447 | 155 | 10 | C3714756 | |
| Disease | total lipids in medium VLDL | 1.89e-04 | 54 | 155 | 4 | EFO_0022153 | |
| Disease | alpha fetoprotein measurement | 1.89e-04 | 100 | 155 | 5 | EFO_0010583 | |
| Disease | leukemia | 2.03e-04 | 55 | 155 | 4 | C0023418 | |
| Disease | triglycerides in LDL measurement | 2.18e-04 | 56 | 155 | 4 | EFO_0022320 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.18e-04 | 229 | 155 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | triglycerides in IDL measurement | 2.49e-04 | 58 | 155 | 4 | EFO_0022149 | |
| Disease | phospholipids in VLDL measurement | 2.66e-04 | 59 | 155 | 4 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 2.84e-04 | 60 | 155 | 4 | EFO_0022314 | |
| Disease | free cholesterol in VLDL measurement | 3.03e-04 | 61 | 155 | 4 | EFO_0022276 | |
| Disease | triglycerides in medium LDL measurement | 3.22e-04 | 62 | 155 | 4 | EFO_0022322 | |
| Disease | cholesterol in large VLDL measurement | 3.87e-04 | 65 | 155 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.87e-04 | 65 | 155 | 4 | EFO_0022230 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | total lipids in small VLDL | 4.34e-04 | 67 | 155 | 4 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 4.59e-04 | 68 | 155 | 4 | EFO_0022144 | |
| Disease | Global developmental delay | 7.02e-04 | 133 | 155 | 5 | C0557874 | |
| Disease | Embryonal Rhabdomyosarcoma | 7.52e-04 | 8 | 155 | 2 | C0206656 | |
| Disease | eosinophil count | HIVEP2 SPEF2 PARP8 ZMYND8 IRAK2 ANKLE2 CEP43 WAC HIVEP3 SETD2 FAM193A TBC1D1 ZBTB40 TMEM131 PLCB3 N4BP1 PEAK1 TP53BP1 | 8.50e-04 | 1488 | 155 | 18 | EFO_0004842 |
| Disease | level of Sphingomyelin (d36:1) in blood serum | 9.63e-04 | 9 | 155 | 2 | OBA_2045178 | |
| Disease | neutrophil count | HIVEP2 PARP8 ASH1L MAML1 ADAR CDC14A TGOLN2 HIVEP3 SETD2 PTPRA PRPF4 SLMAP NCOA1 AFF1 RPRD2 RP1 LRBA | 9.92e-04 | 1382 | 155 | 17 | EFO_0004833 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.11e-03 | 220 | 155 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | lung cancer (is_marker_for) | 1.13e-03 | 39 | 155 | 3 | DOID:1324 (is_marker_for) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.20e-03 | 150 | 155 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.22e-03 | 224 | 155 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.25e-03 | 225 | 155 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Colorectal Carcinoma | MYC ANK2 MAP1B TCOF1 PARP8 CINP CDC14A WAC HIVEP3 CCDC62 MKI67 | 1.26e-03 | 702 | 155 | 11 | C0009402 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.28e-03 | 152 | 155 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | outer ear morphology trait | 1.75e-03 | 12 | 155 | 2 | EFO_0007664 | |
| Disease | brain disease (is_implicated_in) | 1.75e-03 | 12 | 155 | 2 | DOID:936 (is_implicated_in) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.88e-03 | 166 | 155 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | Neuroblastoma | 1.95e-03 | 47 | 155 | 3 | C0027819 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.06e-03 | 13 | 155 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | sphingomyelin 18:1 measurement | 2.06e-03 | 13 | 155 | 2 | EFO_0010394 | |
| Disease | Retinitis Pigmentosa | 2.24e-03 | 104 | 155 | 4 | C0035334 | |
| Disease | Leukemia, Myelocytic, Acute | 2.25e-03 | 173 | 155 | 5 | C0023467 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | chronotype measurement | CYLC1 TSHZ3 ANK2 RBBP6 PODXL FNBP4 TNRC6B ZNF318 CLIP1 FAM193A TET1 RPRD2 | 2.48e-03 | 882 | 155 | 12 | EFO_0008328 |
| Disease | gallstones | 2.57e-03 | 108 | 155 | 4 | EFO_0004210 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.59e-03 | 260 | 155 | 6 | EFO_0008317 | |
| Disease | reaction time measurement | 2.59e-03 | 658 | 155 | 10 | EFO_0008393 | |
| Disease | hematocrit | CCDC192 TDRD15 HIVEP2 ASH1L AAK1 TNRC6B ZBTB40 ANKRD17 NCOA7 AFF1 PLCB3 ARHGAP21 TP53BP1 | 2.70e-03 | 1011 | 155 | 13 | EFO_0004348 |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.75e-03 | 53 | 155 | 3 | C1961099 | |
| Disease | triglycerides in medium VLDL measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0022155 | |
| Disease | factor VII activating protease measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0009368 | |
| Disease | phosphatidylcholine 38:6 measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0010388 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.38e-03 | 57 | 155 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small LDL percentage | 3.73e-03 | 59 | 155 | 3 | EFO_0022337 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.73e-03 | 59 | 155 | 3 | EFO_0022248 | |
| Disease | reticulocyte measurement | ASH1L TNRC6B IP6K1 CLIP1 UBE2O PTPRA ZBTB40 NCOA7 RSRP1 TMEM131 PLCB3 TNS1 ARHGAP21 | 3.81e-03 | 1053 | 155 | 13 | EFO_0010700 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.87e-03 | 121 | 155 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | syndrome (implicated_via_orthology) | 3.97e-03 | 18 | 155 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | triglycerides in small VLDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022274 | |
| Disease | coronary artery disease | TDRD15 VPS11 HIVEP2 REPS1 MAP1B MAP6 PARP8 AAK1 HIRA IGF2R RPRD2 RP1 TNS1 ARHGAP21 | 4.26e-03 | 1194 | 155 | 14 | EFO_0001645 |
| Disease | phospholipids in large VLDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022169 | |
| Disease | phospholipids in very large VLDL measurement | 4.29e-03 | 62 | 155 | 3 | EFO_0022299 | |
| Disease | triglycerides in small LDL measurement | 4.89e-03 | 65 | 155 | 3 | EFO_0022323 | |
| Disease | peak expiratory flow | 4.95e-03 | 498 | 155 | 8 | EFO_0009718 | |
| Disease | Tinnitus | 4.99e-03 | 130 | 155 | 4 | HP_0000360 | |
| Disease | neutrophil percentage of leukocytes | 5.09e-03 | 610 | 155 | 9 | EFO_0007990 | |
| Disease | breast carcinoma (is_marker_for) | 5.11e-03 | 66 | 155 | 3 | DOID:3459 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKSETEQETTTKLAP | 291 | Q5W0A0 | |
| TPDESTKTKDQILTS | 751 | Q86XL3 | |
| GEKKTEESSQEPQST | 2896 | Q9NR48 | |
| CPTKETSTKASTNVD | 396 | Q9BXX2 | |
| TSSEPVAKESTEASK | 576 | Q96G01 | |
| ETESSSNKKNSPTSL | 591 | Q6P9F0 | |
| AEASLNKSKSATTTP | 661 | Q2M2I8 | |
| VSSAKEKSSPSATEK | 156 | Q58F21 | |
| ATDDPENKKTSSSSK | 491 | Q9UNH5 | |
| KPKDSDKEGTSNSTS | 161 | Q9P0M6 | |
| ISESESEETNAPKKT | 76 | P54259 | |
| TVEKEATFSNPKTTS | 431 | O75534 | |
| QPALKDTSDKDDSVS | 306 | A6QL64 | |
| PAEKATSDDKDSVSN | 551 | A6QL64 | |
| KQPASKATSDKTDSA | 651 | A6QL64 | |
| KQPASKTASDKTDSA | 361 | Q8N2N9 | |
| ATSDKKDSVSNIPTE | 571 | Q8N2N9 | |
| SSEKAKEPETSDQTS | 601 | Q58WW2 | |
| KEPETSDQTSTESAT | 606 | Q58WW2 | |
| PEKVNGESKSSSTSE | 1596 | O75179 | |
| KTDTNVSKPSFAAES | 816 | Q6W2J9 | |
| DSETSKPQESFEKNS | 941 | Q9UKL3 | |
| NSSETKPVSSTRAAK | 856 | P78312 | |
| EESSDKSPETVNRSK | 61 | Q5VWP3 | |
| VSPQSTLETKESKSF | 171 | O95156 | |
| ESQSLPKKVSLSSDT | 271 | Q96B01 | |
| CKSEEPDSITKSISS | 2791 | P49792 | |
| KVKNLSASFPTEESS | 1616 | Q99666 | |
| KVKNLSASFPTEESS | 1616 | O14715 | |
| SQTTPSKDTDDQSRK | 266 | Q99504 | |
| NEETPSSKEATAETT | 1666 | Q96PE2 | |
| SSSSESEPELAQLKK | 2661 | Q01484 | |
| EEKKDPESSGSATQT | 276 | Q92585 | |
| KPASSSSLTQEKVSS | 261 | Q8NGM9 | |
| ESPKSTKSADTTTVA | 121 | O00592 | |
| KVSAKDEPASSSKSS | 751 | Q8N3A8 | |
| STSTTKRPKSIDDSE | 271 | Q14938 | |
| EESPSKETSLDVSSK | 1201 | P78559 | |
| DSISAVSSEKVSPSK | 1241 | P46821 | |
| EAKESLAQPVSDSSK | 436 | Q96JE9 | |
| SKSQAQSTDSSKDPT | 451 | Q99456 | |
| TSSDSKDFSTSIPKQ | 171 | O43187 | |
| VISRPDSSSTKSKED | 166 | Q5H9T9 | |
| SEDPKSSDSENSVTK | 841 | Q8NCM2 | |
| STISSTKTKEPEDNL | 6026 | Q5CZC0 | |
| EKEEQSTNSTLDPSK | 46 | A6PVY3 | |
| ETSISGPSKEASDKT | 8076 | Q7Z5P9 | |
| ESKVPDNTTSKTTDC | 671 | Q9H792 | |
| QSKKSKSSSETNPES | 171 | P35663 | |
| QKTATSETAKPLSSE | 51 | Q6UY01 | |
| KSSPSKENESSDSEE | 2481 | Q6KC79 | |
| SKSSEDLKPCDTSST | 466 | Q6ZU52 | |
| DLDTKATPSVSVSKN | 1661 | P50851 | |
| QADDSTKPTNKASST | 1341 | P35658 | |
| TSVSVKPSEEKTSES | 401 | P31644 | |
| KKSSESTTCSIPQFE | 86 | P59047 | |
| TEIESTSPKSEQDSG | 256 | Q9Y2D4 | |
| TKTSDTETEPSKTVS | 856 | P46013 | |
| PDHTEESTTDDKTTK | 2086 | P46013 | |
| KAEESSEKSSSSPCV | 306 | P49639 | |
| AEAEKVNTTASSSPS | 31 | A6NCF6 | |
| SNTKEPSEKLESTSS | 1226 | Q7Z6E9 | |
| EDKSDAASNSVTETP | 136 | A6NF01 | |
| NTSEDSENFPSSSKK | 511 | Q8IZE3 | |
| KKPTTDEGTASSEVN | 571 | Q01970 | |
| SKVKNLSASFPTEES | 1616 | A6NKT7 | |
| TKEQGSPEKARSSSS | 506 | Q14721 | |
| KESEKTAESQTPTPS | 591 | P55265 | |
| QSDTSVSLSEPKSKS | 201 | O95684 | |
| GTAVTEKTAEDKPSS | 2561 | Q8TD26 | |
| KSNTKESRDSATASP | 146 | Q9H1M3 | |
| NASITPVKSKTSTED | 951 | Q4L180 | |
| EASEAKTSSLKPAVT | 391 | Q8WUF8 | |
| AEVKPDSSSAKRSQT | 356 | Q86X45 | |
| SQEKTSPTKEQSEAE | 246 | A6NNA5 | |
| PESTVTSTVGDKKTD | 181 | Q5U623 | |
| IKDASEQSSSAKATP | 616 | Q9Y4F3 | |
| ETSESSQEAKSPKVE | 141 | Q92551 | |
| EETVFTASKPKSSST | 1331 | Q8WYP5 | |
| ETKKSPVSSTQEIDS | 1366 | Q5T890 | |
| SSDSDEKVPLAKASS | 611 | P54198 | |
| KKSVVPESDTSERSS | 26 | P0DO97 | |
| SRKTSSEKVNPESSG | 471 | Q7Z2K8 | |
| APSETASASKEKETS | 1096 | Q9ULU4 | |
| SSEVSKPKLESESTS | 651 | Q5VT52 | |
| ESKKEDTTAVTTTAP | 276 | O95104 | |
| SEDSSPSQRDKKDLS | 56 | Q9BR46 | |
| APVEKTISSEKASST | 31 | P30622 | |
| DKETASAIKSSESPR | 386 | Q8IXS8 | |
| GSKTSSSDTLSEEKN | 876 | Q9BXW9 | |
| KDGSADTKPTQVDTS | 696 | Q6UXK5 | |
| EEPKKSTTSASTSEE | 166 | Q8N5F7 | |
| NSSTAEPVKEEAKTS | 36 | P18433 | |
| SSKSTENSPKETQEP | 851 | A6NGG8 | |
| QNSSSEESPKKDTEP | 1221 | A6NGG8 | |
| ELSSEAKTKSESTSG | 226 | Q6UXV4 | |
| TTVSKTGPSNNDEKS | 351 | P56715 | |
| EPSSSKDSDENSKPS | 541 | Q96PC5 | |
| SSDVCPTSDKSKVVS | 1266 | P11717 | |
| VKASIPSAEKTSSTD | 1661 | Q9C093 | |
| SKISSEEEKASFPSQ | 951 | Q96KN7 | |
| EESTKKLPNDSDLTS | 741 | Q7Z5M5 | |
| KTEEKTAASAPANVS | 676 | Q96D71 | |
| PESQSKTSETSKGST | 1221 | O43426 | |
| STESVKVSSALSPSK | 241 | B5MCY1 | |
| AQVKASSVSTKESPA | 221 | Q13428 | |
| LKDKTGTDSNSTESS | 651 | Q8N3X1 | |
| TVTKLSKEPSDTSSA | 386 | Q8NI08 | |
| ASSTQATKTKAPDDL | 6 | O43172 | |
| KCTSPRSSDTEENVK | 341 | P01106 | |
| SVEPDKKDSASTSVS | 706 | Q15788 | |
| RTAAKEPKTSASDSQ | 1116 | P28715 | |
| EPKTSASDSQNSVKE | 1121 | P28715 | |
| SSSQEKDPKIKTETS | 776 | Q9Y6Q9 | |
| DSTAGTTKQPSKEEE | 346 | Q8IY81 | |
| SSADATTSSEELPKK | 166 | Q9Y535 | |
| SSVPAQKTERKESTS | 296 | Q9BTA9 | |
| RLPSESKKEDSSDAT | 156 | Q9NX31 | |
| SSSSKSQDKTLLPTE | 351 | Q9UPV7 | |
| QSIEKTSAKDLAPTS | 311 | Q92954 | |
| SESDSSGETKDTLKP | 251 | P11831 | |
| KSAKAATEEASSRSP | 261 | Q9BUV0 | |
| VSSDESSSGENKSKK | 666 | Q08945 | |
| SEAPSENSSPSKSEK | 901 | Q8NFU7 | |
| SSPTKKSKSTEDGAE | 5706 | Q8IVF2 | |
| SLKSFSDATAPTQEK | 1031 | P51825 | |
| QESSKIPESSSDKVA | 476 | Q96JQ2 | |
| LDSSSPASKENEEKV | 66 | Q9BW66 | |
| GTPKESSTESSQSAK | 481 | Q96S66 | |
| DSETEDTNASPEKTT | 66 | Q9HAW4 | |
| ESFAKETSSPKSNLE | 236 | Q8IYJ2 | |
| DAKKSTSAETETPQS | 861 | P63136 | |
| SKIKGSPDVSASSDE | 46 | Q9BVW6 | |
| SKSGAEEQTSKDSPN | 236 | O43493 | |
| ASTPTTVSDGENKKD | 281 | Q9Y320 | |
| KSTSSKEAEFTSEPA | 266 | Q5JXA9 | |
| SSSKETEQPSTKAVI | 951 | Q15468 | |
| NSSTPKSKTVESAEG | 361 | P82094 | |
| KDTTEVPSSTVEKSN | 146 | O15164 | |
| KVSPKSEFTSRDSQS | 291 | Q9H270 | |
| EKISSSGTAKESPSS | 146 | Q9Y5A6 | |
| STEKDASPKTSTSLG | 496 | Q9BW04 | |
| KTRESTSSEKVSQSP | 176 | Q9P2W9 | |
| TSSEKVSQSPSKDSE | 181 | Q9P2W9 | |
| DFSDTLSPSKEKSSD | 446 | Q14BN4 | |
| LSPSKEKSSDDTTDA | 451 | Q14BN4 | |
| SSIVNSSSSSDPKIK | 1621 | Q92545 | |
| SGNSTASTKTDKTDE | 406 | Q9HBL0 | |
| STLSNTSKEPSVCEK | 536 | Q86TI0 | |
| SKTKSEAESASPEET | 421 | Q9C0C9 | |
| TSEDVKASPSSANKR | 426 | O15014 | |
| SKSPTISDKTSQERD | 1311 | O15014 | |
| TSSRPAKSQEGTDSK | 1576 | Q5T1R4 | |
| TVECSKTSEIEPKNS | 486 | Q12888 | |
| ASDKDITVSKNTSLP | 191 | P49790 | |
| ETEQKSESFSSIEKP | 776 | Q9UBS9 | |
| SVSKDIDSSDRKSPT | 251 | Q8IYW5 | |
| KSSTPSSISEKSDID | 861 | Q63HK5 | |
| ASKKPKTAEADTSSE | 2451 | Q9BYW2 | |
| RKPSTSDDSDSNFEK | 1466 | P11388 | |
| KASSPSDIISSKDSV | 961 | Q9ULD9 | |
| TSATEADQDPTTSKS | 496 | Q9H0C3 | |
| SQGRTPKADTSTDKS | 76 | Q6P9A1 | |
| DAKKSTSAETETPQS | 866 | Q9WJR5 | |
| GSTKDDELASTTTPK | 826 | Q9C0G0 | |
| KLSAQSPESKFSAET | 171 | Q86VR7 | |
| EKSSDNVNSEIKSTP | 76 | Q9BXT5 | |
| TARDSEDTPKSSSKN | 811 | Q8TDI7 | |
| KELSSSTEESKDPSS | 2426 | P31629 | |
| STEESKDPSSEKSQL | 2431 | P31629 | |
| SSKDSEDTSKEPSLS | 1151 | Q14679 | |
| DVSDSATSDSTKSKG | 1381 | Q5T5U3 | |
| DKSQKSLSDSREPTE | 986 | Q5VUA4 | |
| EKSKSPEKVSSFSNS | 1006 | Q5VUA4 | |
| PEKVSSFSNSSSNKE | 1011 | Q5VUA4 | |
| SDPKAKSVQSSNSTT | 261 | Q9UPQ9 | |
| SPAVQTFSEAKKTST | 216 | Q9NUA8 | |
| SSTNELTTDSTPKKT | 416 | O75113 |